albendazole has been researched along with Coenuri Infection in 214 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a randomized, controlled study, the efficacy and safety of two different schemes of albendazole therapy for treatment of porcine cysticercosis were tested." | 9.08 | Treatment of porcine cysticercosis with albendazole. ( Garcia, HH; Gavidia, C; Gilman, RH; Gonzalez, AE; Lopez, MT; McDonald, J; Pilcher, JB; Tsang, VC, 1995) |
| "Albendazole is considered the drug of choice for neurocysticercosis." | 9.08 | Therapy for neurocysticercosis: pharmacokinetic interaction of albendazole sulfoxide with dexamethasone. ( Bonato, PS; Lanchote, VL; Marques, MP; Takayanagui, OM, 1997) |
| "To compare the effectiveness of two regimens of albendazole therapy for neurocysticercosis." | 9.08 | Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment. Cysticercosis Working Group in Peru. ( Altamirano, J; Boero, J; Cuba, JM; Garcia, HH; Gilman, RH; Gonzalez, AE; Herrera, G; Horton, J; Martinez, M; Rios-Saavedra, N; Verastegui, M, 1997) |
| "The purpose of this study was to determine the therapeutic efficacy of albendazole and praziquantel administration in the treatment of neurocysticercosis of the fourth ventricle." | 9.08 | Albendazole and praziquantel treatment in neurocysticercosis of the fourth ventricle. ( Correa, D; García, L; García-Torres, E; Madrazo, I; Proaño, JV, 1997) |
| "We treated 11 patients with a persistent (> 3 months), solitary small cysticercus granuloma and seizures with albendazole in a daily dose of 15 mg/kg body weight for 14 days." | 9.07 | Albendazole therapy for persistent, solitary cysticercus granulomas in patients with seizures. ( Rajshekhar, V, 1993) |
| "Praziquantel and albendazole have been recently described as effective drugs for treatment of intraparenchymal brain cysticercosis." | 9.07 | Therapy for neurocysticercosis. Comparison between albendazole and praziquantel. ( Jardim, E; Takayanagui, OM, 1992) |
| "One hundred consecutive patients presenting with symptoms and signs of neurocysticercosis, confirmed by neuroimaging techniques were randomly assigned to treatment with either praziquantel 50 mg/kg/day for 15 days or albendazole 15 mg/kg/day for 30 days." | 9.07 | Clinical evaluation of albendazole and praziquantel in the treatment of cerebral cysticercosis. ( Cruz, I; Cruz, M; Horton, J, 1991) |
| "To report the occurrence of optic neuritis following oral albendazole therapy for orbital cysticercosis." | 7.70 | Optic neuritis following albendazole therapy for orbital cysticercosis. ( Dada, T; Sihota, R; Tandon, R; Verma, L, 1998) |
| "Albendazole, a newer paracidal drug, seems to be more effective and less expensive than some other drugs in use for the treatment of neurocysticercosis." | 7.69 | Cerebral and subcutaneous cysticercosis treated with albendazole. ( Cilliers, J; Jordaan, HF; Schmidt, DK; Schneider, JW, 1995) |
| "Albendazole has been used successfully in the treatment of cerebral cysticercosis for several years." | 7.69 | Neurocysticercosis: optimal dose treatment with albendazole. ( Carrasco, F; Cruz, I; Cruz, ME; Horton, J, 1995) |
| "Study of 22 patients with the severe form of neurocysticercosis treated with albendazole (ABZ) administered in 6 different schedules ranging from 15 to 30 mg/kg/day for 21 to 60 days." | 7.69 | Severe forms of neurocysticercosis: treatment with albendazole. ( Agapejev, S; Da Silva, MD; Ueda, AK, 1996) |
| "A patient with orbital cysticercosis is being presented, where albendazole therapy was successfully used." | 7.69 | Albendazole therapy in orbital cysticercosis. ( Singhal, KC; Srivastava, A; Srivastava, VK, 1996) |
| "The authors report a case of neurocysticercosis treated with Albendazole (methyl-5-propyl-thio-2-benzimidazilcarbamate)." | 7.69 | Neurocysticercosis treated with albendazole long term follow-up of a case. ( Maddalena, G; Nozzoli, C; Passarella, B, 1995) |
| "Ten cases of cerebral cysticercosis, treated with 2-week course of albendazole, were reported." | 7.68 | Treatment of neurocysticercosis with a two week course of albendazole. ( Chotmongkol, V, 1993) |
| "Albendazole pharmacokinetics were studied in eight patients who were receiving albendazole in doses of 15 mg/kg per day for 8 days as treatment of brain cysticercosis." | 7.68 | Clinical pharmacokinetics of albendazole in patients with brain cysticercosis. ( Hurtado, M; Jung, H; Medina, MT; Sanchez, M; Sotelo, J, 1992) |
| "Albendazole or praziquantel were measured in plasma and cerebrospinal fluid (CSF) in 29 patients with neurocysticercosis." | 7.68 | Plasma and CSF levels of albendazole and praziquantel in patients with neurocysticercosis. ( Hurtado, M; Jung, H; Medina, MT; Sanchez, M; Sotelo, J, 1990) |
| "Albendazole is now used for therapy of neurocysticercosis; however, duration of treatment has usually been empirically determined." | 7.67 | Short course of albendazole therapy for neurocysticercosis. ( Del Brutto, OH; Escobedo, F; Penagos, P; Sotelo, J, 1988) |
| "Praziquantel and albendazole have been recently described as effective drugs for treating cysticercosis of the brain." | 7.67 | Albendazole vs praziquantel for therapy for neurocysticercosis. A controlled trial. ( Escobedo, F; Penagos, P; Sotelo, J, 1988) |
| "Seven patients with chronic parenchymal brain cysticercosis were treated with albendazole for one month at daily doses of 15 mg/kg of body weight." | 7.67 | Albendazole therapy for neurocysticercosis. ( Escobedo, F; Penagos, P; Rodriguez, J; Sotelo, J, 1987) |
| "Albendazole was administered orally in a dose of 15 mg/kg bodyweight/day for 30 days without prophylactic steroids." | 6.67 | Albendazole therapy for neurocysticercosis. ( Dhamija, RM; Roy, AK; Sanchetee, PC; Venkataraman, S, 1994) |
| "To evaluate two different dosage regimens for albendazole (7." | 6.67 | Pharmacokinetic comparison of two albendazole dosage regimens in patients with neurocysticercosis. ( González-Esquivel, D; Jung, H; Sánchez, M; Sotelo, J; Suástegui, R, 1993) |
| "Albendazole treatment seems to reduce the lesion load and improve symptoms." | 6.53 | Disseminated cysticercosis: clinical spectrum, Toll-like receptor-4 gene polymorphisms and role of albendazole: A prospective follow-up of 60 cases with a review of 56 published cases. ( Garg, RK; Jain, A; Kumar, N; Malhotra, HS; Malhotra, KP; Qavi, A; Sharma, PK; Srivastava, PK; Verma, R, 2016) |
| "Nitazoxanide (NTZ) has been experimentally tested against this parasite." | 5.72 | Intraperitoneal and intracranial experimental cysticercosis present different metabolic preferences after treatment with isolated or combined albendazole and nitazoxanide. ( Cristina Gomes, T; de Andrade Picanço, G; de Sousa Mendes Moreira Alves, D; Ferreira de Lima, N; Luísa da Costa, T; Vinaud, MC, 2022) |
| "Cysticercosis is a neglected tropical disease set as health priority by WHO." | 5.56 | [Disseminated cysticercosis affecting the brain, the eye and the skin on a Senegalese patient]. ( Diallo, K; Diallo, M; Dione, MAD; Diop, A; Manga, NM; Wembulua, BS, 2020) |
| " The 15 mg/kg per body weight dosage of ABZSO was 100% effective against muscular cysticercosis as shown by the lack of viable cysts and the micro-calcifications in meat from the treated pigs." | 5.31 | Chemotherapy of porcine cysticercosis with albendazole sulphoxide. ( Argaez-Rodriguez, F; Craig, PS; Dominguez-Alpizar, JL; Fraser, A; Peniche-Cardeña, A; Rodriguez-Canul, R; Sima-Alvarez, R, 2002) |
| "Treatment with praziquantel resulted in the regression of only some of the cysts." | 5.28 | [Selective sensitivity of cysts to praziquantel and albendazole in a case of cerebral cysticercosis]. ( Belec, L; Cohen, L; Pierrot-Deseilligny, C; Sanson, M; Signoret, JL, 1992) |
| "In a randomized, controlled study, the efficacy and safety of two different schemes of albendazole therapy for treatment of porcine cysticercosis were tested." | 5.08 | Treatment of porcine cysticercosis with albendazole. ( Garcia, HH; Gavidia, C; Gilman, RH; Gonzalez, AE; Lopez, MT; McDonald, J; Pilcher, JB; Tsang, VC, 1995) |
| "Randomized clinical trial of treatment of patients with newly identified active neurocysticercosis with oral prednisolone alone (27 patients), praziquantel with prednisolone (54 patients), or albendazole with prednisolone (57 patients)." | 5.08 | Is the course of neurocysticercosis modified by treatment with antihelminthic agents? ( Carpio, A; Flores, C; Hauser, WA; León, P; Santillán, F, 1995) |
| "Albendazole is considered the drug of choice for neurocysticercosis." | 5.08 | Therapy for neurocysticercosis: pharmacokinetic interaction of albendazole sulfoxide with dexamethasone. ( Bonato, PS; Lanchote, VL; Marques, MP; Takayanagui, OM, 1997) |
| "To compare the effectiveness of two regimens of albendazole therapy for neurocysticercosis." | 5.08 | Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment. Cysticercosis Working Group in Peru. ( Altamirano, J; Boero, J; Cuba, JM; Garcia, HH; Gilman, RH; Gonzalez, AE; Herrera, G; Horton, J; Martinez, M; Rios-Saavedra, N; Verastegui, M, 1997) |
| "The purpose of this study was to determine the therapeutic efficacy of albendazole and praziquantel administration in the treatment of neurocysticercosis of the fourth ventricle." | 5.08 | Albendazole and praziquantel treatment in neurocysticercosis of the fourth ventricle. ( Correa, D; García, L; García-Torres, E; Madrazo, I; Proaño, JV, 1997) |
| "To evaluate the efficacy of albendazole in the management of orbital myocysticercosis." | 5.08 | Medical management of orbital myocysticercosis: a pilot study. ( Grover, AK; Puri, P, 1998) |
| "We treated 11 patients with a persistent (> 3 months), solitary small cysticercus granuloma and seizures with albendazole in a daily dose of 15 mg/kg body weight for 14 days." | 5.07 | Albendazole therapy for persistent, solitary cysticercus granulomas in patients with seizures. ( Rajshekhar, V, 1993) |
| "Praziquantel and albendazole have been recently described as effective drugs for treatment of intraparenchymal brain cysticercosis." | 5.07 | Therapy for neurocysticercosis. Comparison between albendazole and praziquantel. ( Jardim, E; Takayanagui, OM, 1992) |
| "One hundred consecutive patients presenting with symptoms and signs of neurocysticercosis, confirmed by neuroimaging techniques were randomly assigned to treatment with either praziquantel 50 mg/kg/day for 15 days or albendazole 15 mg/kg/day for 30 days." | 5.07 | Clinical evaluation of albendazole and praziquantel in the treatment of cerebral cysticercosis. ( Cruz, I; Cruz, M; Horton, J, 1991) |
| "The efficacy of different regimens of therapy for parenchymal brain cysticercosis either with praziquantel (PZQ) or with albendazole (ALB) was compared in 114 patients." | 5.06 | Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis. ( del Brutto, OH; Escobedo, F; Penagos, P; Rodriguez-Carbajal, J; Rubio-Donnadieu, F; Sotelo, J; Torres, B, 1990) |
| "The current pharmacological treatment of neurocysticercosis is based on two drugs, praziquantel (PZQ) and albendazole; however, suboptimal efficacy has been documented." | 3.96 | Cysticidal activity of praziquantel-mebendazole combination: In vitro and in vivo studies. ( Fernanda, GM; Francisca, PA; Guadalupe, PH; Helgi, JC; Iliana, GH; Javier, LF; Nelly, C; Susana, RI, 2020) |
| " At these times, and again in October 2014, eligible village pigs received the anti-cysticercosis TSOL18 vaccination and an oral dose of oxfendazole anthelmintic at 30mg/kg, both repeated one month later." | 3.83 | Assessing the impact of a joint human-porcine intervention package for Taenia solium control: Results of a pilot study from northern Lao PDR. ( Allen, J; Ash, A; Dorny, P; Gabriël, S; Gauci, CG; Inthavong, P; Keokamphet, C; Khamlome, B; Lightowlers, MW; Newberry, K; Okello, AL; Thomas, L; Thompson, RA, 2016) |
| "Our results suggest that nitazoxanide in combination with albendazole could be useful for treatment of cysticercosis infections." | 3.74 | Efficacy of nitazoxanide, tizoxanide and tizoxanide/albendazole sulphoxide combination against Taenia crassiceps cysts. ( Jung-Cook, H; Ortiz-Plata, A; Palencia, G; Palomares-Alonso, F; Piliado, JC, 2007) |
| "To study the incidence of adverse reactions to albendazole therapy in patients presenting with seizures and a persistent (>3 months after diagnosis), solitary cysticercus granuloma and to determine whether the occurrence of adverse reactions predicted the response of the granuloma to therapy." | 3.70 | Incidence and significance of adverse effects of albendazole therapy in patients with a persistent solitary cysticercus granuloma. ( Rajshekhar, V, 1998) |
| "To report the occurrence of optic neuritis following oral albendazole therapy for orbital cysticercosis." | 3.70 | Optic neuritis following albendazole therapy for orbital cysticercosis. ( Dada, T; Sihota, R; Tandon, R; Verma, L, 1998) |
| "To compare computed tomography (CT) and B-scan ultrasonography (USG) in the diagnosis and to study the efficacy of a combination of oral albendazole and prednisolone in the management of myocysticercosis." | 3.70 | Myocysticercosis: experience with imaging and therapy. ( Honavar, SG; Sekhar, GC, 1999) |
| "Albendazole, a newer paracidal drug, seems to be more effective and less expensive than some other drugs in use for the treatment of neurocysticercosis." | 3.69 | Cerebral and subcutaneous cysticercosis treated with albendazole. ( Cilliers, J; Jordaan, HF; Schmidt, DK; Schneider, JW, 1995) |
| "The dynamics of circulating antigen (CAg) level in sera form patients with cysticercosis before and after albendazole treatment were detected by using monoclonal antibody-based double antibody sandwich ELISA (McAb-ELISA)." | 3.69 | [Observation on dynamics of circulating antigen from patients with cysticercosis before and after treatment]. ( Lei, J; Li, C; Wan, X; Zhang, M; Zhang, Y, 1995) |
| "Albendazole has been used successfully in the treatment of cerebral cysticercosis for several years." | 3.69 | Neurocysticercosis: optimal dose treatment with albendazole. ( Carrasco, F; Cruz, I; Cruz, ME; Horton, J, 1995) |
| "Study of 22 patients with the severe form of neurocysticercosis treated with albendazole (ABZ) administered in 6 different schedules ranging from 15 to 30 mg/kg/day for 21 to 60 days." | 3.69 | Severe forms of neurocysticercosis: treatment with albendazole. ( Agapejev, S; Da Silva, MD; Ueda, AK, 1996) |
| "Report of a patient with the hydrocephalic and meningoencephalitic form of neurocysticercosis who simultaneously developed polyradiculoneuropathy and intracranial hypertension syndrome during the first week of treatment with albendazole." | 3.69 | [Polyradiculoneuritis and neurocysticercosis: report of a case]. ( Agapejev, S; Da Silva, MD; De Lima Resende, LA, 1996) |
| "A patient with orbital cysticercosis is being presented, where albendazole therapy was successfully used." | 3.69 | Albendazole therapy in orbital cysticercosis. ( Singhal, KC; Srivastava, A; Srivastava, VK, 1996) |
| "The authors report a case of neurocysticercosis treated with Albendazole (methyl-5-propyl-thio-2-benzimidazilcarbamate)." | 3.69 | Neurocysticercosis treated with albendazole long term follow-up of a case. ( Maddalena, G; Nozzoli, C; Passarella, B, 1995) |
| "Ten cases of cerebral cysticercosis, treated with 2-week course of albendazole, were reported." | 3.68 | Treatment of neurocysticercosis with a two week course of albendazole. ( Chotmongkol, V, 1993) |
| "Albendazole is considered to be the drug of choice for treatment of parenchymal brain cysticercosis." | 3.68 | Albendazole therapy for giant subarachnoid cysticerci. ( Aguirre, R; Alarcón, TA; Del Brutto, OH; Díaz-Calderón, E; Sotelo, J, 1992) |
| "Albendazole pharmacokinetics were studied in eight patients who were receiving albendazole in doses of 15 mg/kg per day for 8 days as treatment of brain cysticercosis." | 3.68 | Clinical pharmacokinetics of albendazole in patients with brain cysticercosis. ( Hurtado, M; Jung, H; Medina, MT; Sanchez, M; Sotelo, J, 1992) |
| "Albendazole or praziquantel were measured in plasma and cerebrospinal fluid (CSF) in 29 patients with neurocysticercosis." | 3.68 | Plasma and CSF levels of albendazole and praziquantel in patients with neurocysticercosis. ( Hurtado, M; Jung, H; Medina, MT; Sanchez, M; Sotelo, J, 1990) |
| "Albendazole is now used for therapy of neurocysticercosis; however, duration of treatment has usually been empirically determined." | 3.67 | Short course of albendazole therapy for neurocysticercosis. ( Del Brutto, OH; Escobedo, F; Penagos, P; Sotelo, J, 1988) |
| "Praziquantel and albendazole have been recently described as effective drugs for treating cysticercosis of the brain." | 3.67 | Albendazole vs praziquantel for therapy for neurocysticercosis. A controlled trial. ( Escobedo, F; Penagos, P; Sotelo, J, 1988) |
| "Seven patients with chronic parenchymal brain cysticercosis were treated with albendazole for one month at daily doses of 15 mg/kg of body weight." | 3.67 | Albendazole therapy for neurocysticercosis. ( Escobedo, F; Penagos, P; Rodriguez, J; Sotelo, J, 1987) |
| "Neurocysticercosis is a parasitic infection of the central nervous system by tapeworm larvae." | 3.01 | Spinal nerve root sleeve cysticercosis: a case report and review of the literature. ( Ji, K; Li, T; Shang, A; Tao, B, 2023) |
| "Neurocysticercosis is the main cause of acquired epilepsy in developing countries and is an emerging disease in the United States." | 2.68 | Serologic evolution of neurocysticercosis patients after antiparasitic therapy. Cysticercosis Working Group in Peru. ( Catacora, M; Garcia, HH; Gilman, RH; Gonzalez, AE; Tsang, VC; Verastegui, M, 1997) |
| "Albendazole was administered orally in a dose of 15 mg/kg bodyweight/day for 30 days without prophylactic steroids." | 2.67 | Albendazole therapy for neurocysticercosis. ( Dhamija, RM; Roy, AK; Sanchetee, PC; Venkataraman, S, 1994) |
| "To evaluate two different dosage regimens for albendazole (7." | 2.67 | Pharmacokinetic comparison of two albendazole dosage regimens in patients with neurocysticercosis. ( González-Esquivel, D; Jung, H; Sánchez, M; Sotelo, J; Suástegui, R, 1993) |
| "Albendazole treatment seems to reduce the lesion load and improve symptoms." | 2.53 | Disseminated cysticercosis: clinical spectrum, Toll-like receptor-4 gene polymorphisms and role of albendazole: A prospective follow-up of 60 cases with a review of 56 published cases. ( Garg, RK; Jain, A; Kumar, N; Malhotra, HS; Malhotra, KP; Qavi, A; Sharma, PK; Srivastava, PK; Verma, R, 2016) |
| "Praziquantel was chosen for treatment of taeniasis and albendazole for treatment of cysticercosis." | 2.50 | Current status of taeniasis and cysticercosis in Vietnam. ( Eom, KS; Le, TH; Lien, PT; Van De, N, 2014) |
| "However, cysticercosis is still a major public health problem in endemic regions, with more than 50 million infected people and is now a re-emerging disease in industrialized countries owing to human migration." | 2.48 | Platyhelminthes in tongue--a rare case and review. ( Dangi, UR; Goyal, AK; Gupta, DS; Jain, R; Jurel, SK; Singh, S; Srivastava, S; Tandon, PN, 2012) |
| "Orbital cysticercosis is secondary to an infestation by cysticercus cellulosae, the larval form of Taenia solium." | 2.47 | Orbital cysticercosis, case report and review. ( Bremner, FD; Elgohary, M; Ziaei, M, 2011) |
| "Albendazole has been found to be the best drug for treating cysticercosis though it does not appear to be totally effective for curing cerebral cysts." | 2.42 | Current status of cysticercosis in Vietnam. ( Cam, PD; Cong, le D; Dalsgaard, A; De, NV; Doanh, NQ; Dorny, P; Dung, TV; Willingham, AL, 2003) |
| "Orbital and adnexal cysticercosis is emerging as a far commoner disease than previously considered, both in endemic and nonendemic areas of cysticercosis." | 2.41 | Orbital and adnexal cysticercosis. ( Bajaj, MS; Betharia, SM; Pushker, N, 2002) |
| "Albendazole has changed from being a drug for individuals with worms to one to treat communities and provide benefit in public health terms." | 2.41 | Albendazole: a broad spectrum anthelminthic for treatment of individuals and populations. ( Horton, J, 2002) |
| " Peak concentration in serum is reached after 1 to 2 hours and the elimination half-life is between 1 and 3 hours." | 2.40 | Pharmacokinetic optimisation of the treatment of neurocysticercosis. ( Jung, H; Sotelo, J, 1998) |
| "Neurocysticercosis is the most important parasitic infection of the nervous system in countries of the third world." | 2.38 | Neurocysticercosis. An introduction with special emphasis on new developments in pharmacotherapy. ( Overbosch, D, 1992) |
| "Treatment with praziquantel or albendazole has hastened the disappearance of the cysts on computed tomography and improved clinical symptoms." | 2.38 | Neurocysticercosis: neurologic, pathogenic, diagnostic and therapeutic aspects. ( Davis, LE; Kornfeld, M, 1991) |
| "Nitazoxanide (NTZ) has been experimentally tested against this parasite." | 1.72 | Intraperitoneal and intracranial experimental cysticercosis present different metabolic preferences after treatment with isolated or combined albendazole and nitazoxanide. ( Cristina Gomes, T; de Andrade Picanço, G; de Sousa Mendes Moreira Alves, D; Ferreira de Lima, N; Luísa da Costa, T; Vinaud, MC, 2022) |
| "Human cysticercosis is an emerging infection caused by the larvae of Taenia solium (Cysticercus cellulosae)." | 1.72 | Isolated Intramuscular Cysticercosis in Children: A Case Report ( Kumar H C, K; Kumar, KJ; Narayana, PS, 2022) |
| "Cysticercosis is a parasitic tissue infection caused by larval cysts of Taenia solium." | 1.72 | [A Histopathologically Diagnosed Neurocysticercosis Case from Türkiye]. ( Akbulut, A; Akgün, B; Balgetir, F; Çalık, M; Enez, M; Özer Balin, Ş; Yıldırım, H, 2022) |
| "Disseminated cysticercosis is an unusual opportunistic infection which can present as subcutaneous nodules without other typical cysticercosis symptoms." | 1.56 | Disseminated cysticercosis and Kaposi sarcoma in a child with HIV/AIDS: A case report. ( Bacha, JM; Campbell, LR; El-Mallawany, NK; Kovarik, CL; McCormick, DW; Slone, JS, 2020) |
| "Cysticercosis is a neglected tropical disease set as health priority by WHO." | 1.56 | [Disseminated cysticercosis affecting the brain, the eye and the skin on a Senegalese patient]. ( Diallo, K; Diallo, M; Dione, MAD; Diop, A; Manga, NM; Wembulua, BS, 2020) |
| "Ocular cysticercosis is a disease which rarely involves cutaneous skin and the optic nerve." | 1.51 | Disseminated neurocysticercosis with bilateral papilledema: a case report. ( Shrestha, AK; Shrestha, R, 2019) |
| "Cysticercosis is an emerging and neglected tropical disease (NTD) that poses a serious public health concern worldwide." | 1.51 | Disseminated cysticercosis in China with complex and variable clinical manifestations: a case series. ( Fan, CK; Huang, MJ; Li, W; Tian, XJ; Wang, F; Wang, HB; Wang, L; Wu, WW; Zhang, HY; Zou, Y, 2019) |
| "Cysticercosis is a parasitic infection caused by larvae known as cysticercus cellulosae." | 1.43 | A rare case of isolated cysticercus involvement of inferior rectus muscle presenting with upward gaze restriction. ( Agrawal, S; Bhadury, S; Khanduri, S; Singh, A, 2016) |
| "Albendazole therapy was found to be more effective in parasite killing than albendazole plus steroid (94." | 1.42 | Immune response to Taenia solium cysticerci after anti-parasitic therapy. ( Gupta, KK; Gupta, RK; Husain, N; Khatoon, J; Prasad, A; Prasad, KN; Rai, RP; Singh, A; Singh, AK; Singh, SK; Tripathi, M, 2015) |
| "Taenia solium cysticercosis is a common parasitic infection of humans and pigs." | 1.42 | Successful Antiparasitic Treatment for Cysticercosis is Associated with a Fast and Marked Reduction of Circulating Antigen Levels in a Naturally Infected Pig Model. ( Bustos, JA; Castillo, Y; Dorny, P; Gabriël, S; Garcia, HH; Gilman, RH; Gonzalez, AE; Praet, N; Rodriguez, S; Zimic, M, 2015) |
| " In a last study with this formulation, this active principle was administered orally, mixed with the mineral supplement, on the 60th DPI, in a dosage of 30mg/kg." | 1.40 | Historic of therapeutic efficacy of albendazol sulphoxide administered in different routes, dosages and treatment schemes, against Taenia saginata cysticercus in cattle experimentally infected. ( Buzzulini, C; Cruz, BC; da Costa, AJ; de Oliveira, GP; Felippelli, G; Lopes, WD; Maciel, WG; Nunes, JL; Pereira, JC; Soares, VE; Soccol, VT; Teixeira, WF, 2014) |
| "Hepatic cysticercosis is a very rare entity; only four cases have been reported to date." | 1.40 | Hepatic cysticercosis: a rare entity. ( Anand, R; Bano, S; Chaudhary, V; Kumar, P; Narula, MK, 2014) |
| "No adverse effects from the treatment occurred." | 1.39 | [A case of cysticercosis with multiple lesions in the brain and femoral muscles]. ( Hirai, T; Niki, Y; Okino, T; Shirakura, T; Shoji, H; Takuma, T; Wakatsuki, Y, 2013) |
| "Cysticercosis is a cause of serious ocular/orbital morbidity." | 1.38 | [Diagnosis of orbital cysticercosis -- a challenge for ophthalmologist]. ( Opincariu, I; Popescu, L; Szabo, B; Szabo, I, 2012) |
| " The aim of this study was to evaluate alterations in glycolysis, the tricarboxylic acid cycle and glucose concentrations caused by low dosage treatments of the hosts with albendazole and praziquantel." | 1.38 | Taenia crassiceps: host treatment alters glycolisis and tricarboxilic acid cycle in cysticerci. ( Bezerra, JC; Costa, TL; de Souza Lino, R; Fraga, CM; Vinaud, MC, 2012) |
| "Cysticercosis is a common tropical disease." | 1.38 | Herculean appearance due to disseminated cysticercosis: case report. ( Jain, S; Kashikar, S; Kumar, S, 2012) |
| "Oral treatment with albendazole and steroids was followed by spontaneous extrusion and resolution of the disease." | 1.37 | Orbital cysticercosis: masquerading as orbital inflammatory disorder. ( Garg, P; Khanduri, S; Malhotra, R; Mishra, R, 2011) |
| "Cysticercosis is a condition that occurs when man is infected with larvae of Taenia solium." | 1.37 | Oral cysticercosis-a rare presentation. ( Aggarwal, G; Chhabra, S; Duhan, A; Kalra, R; Sen, R; Singh, S, 2011) |
| "Intramedullary cysticercosis is a rare form of cysticercosis in the central nervous system." | 1.36 | Intramedullary cysticercosis. ( Abbey, P; Chavda, S; Handa, A; Kumar, S; Tiwari, R, 2010) |
| "Cysticercosis is endemic in developing countries such as India." | 1.35 | Mylohyoid cysticercosis: a rare submandibular mass. ( Ghosh, S; Panda, N; Virk, RS, 2009) |
| "Cysticercosis is not uncommon in developing countries and immigrant population of developed countries." | 1.35 | Cysticercosis of biceps brachii: a rare cause of posterior interosseous nerve syndrome. ( Joshi, A; Nagaraj, C; Singh, S; Trikha, V, 2008) |
| "Cysticercosis is a common parasitic infection caused by encysted larvae of the helminth Taenia solium (pork tapeworm)." | 1.34 | Cysticercosis of temporalis muscle: an unusual cause of temporal headaches. A case report. ( Arsura, E; Sethi, NK; Sethi, PK; Torgovnick, J, 2007) |
| "Human cysticercosis is caused by dissemination of embryos of Taenia solium from the intestine via the hepatoportal system to the tissues and organs of the body." | 1.33 | Disseminated cysticercosis involving orbit, brain and subcutaneous tissue. ( Bajaj, MS; Balasubramanya, R; Pushker, N, 2005) |
| "Cysticercosis is an important public health problem in developing countries." | 1.32 | Disseminated cysticercosis with pulmonary involvement. ( Belucci, AD; Carlos dos Santos, A; Mamere, AE; Muglia, VF; Simão, GN; Takayanagui, OM; Trad, CS, 2004) |
| "Cysticercosis is an helminthic disease which is usually observed in endemic areas or in immigrants coming from these areas." | 1.32 | [Neurocysticercosis complicating the treatment of cutaneous cysticercosis in a traveller]. ( Bricaire, E; Caumes, E; Chemali, N; Danis, M; Epelboin, L; Klement, E, 2004) |
| "Myocardial cysticercosis is an extremely rare infection." | 1.31 | [Myocardial localization of a disseminated cysticercosis. Echocardiographic diagnosis of a case]. ( Barro, F; Cisse, R; Kabore, J; Niakara, A; Niamba, PA; Traore, A, 2002) |
| " The 15 mg/kg per body weight dosage of ABZSO was 100% effective against muscular cysticercosis as shown by the lack of viable cysts and the micro-calcifications in meat from the treated pigs." | 1.31 | Chemotherapy of porcine cysticercosis with albendazole sulphoxide. ( Argaez-Rodriguez, F; Craig, PS; Dominguez-Alpizar, JL; Fraser, A; Peniche-Cardeña, A; Rodriguez-Canul, R; Sima-Alvarez, R, 2002) |
| "To determine the risk of seizure recurrence after a first seizure due to neurocysticercosis (NC) and to evaluate risk factors for seizure recurrence, including the influence of antihelminthic treatment." | 1.31 | Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis. ( Carpio, A; Hauser, WA, 2002) |
| "[corrected] Cysticercosis is a parasitic infestation of different body organs by Cysticercosis cellulosae, a larval form of the helminth, Taenia solium, known commonly as pork tapeworm." | 1.31 | Subretinal cysticercosis. ( Lombardo, J, 2001) |
| "Human cysticercosis is secondary to an infestation by cysticercus cellulosae, the larval form of Taenia solium." | 1.30 | Orbital cysticercosis. ( Lemke, BN; Sekhar, GC, 1997) |
| "Cysticercosis is one of the two infections caused by Taenia solium." | 1.30 | [Enlargement of an extraocular eye muscle: a symptom of cysticercosis]. ( Hasenfratz, G; Hintschich, C; Landau, K; Schriever, S, 1999) |
| "Albendazole has recently been authorized for use in Germany." | 1.29 | [Intraspinal manifestation of cysticercosis--Cysticercus racemosus. A case report and review of the literature]. ( Bogumil-Schott, E; Malzacher, VD; Neu, IS, 1994) |
| "Treatment with albendazole at 15 mg kg-1 body weight daily for 30 days starting from day 0 or 15 days post-infection resulted in 100% cure rates." | 1.29 | Evaluation of the efficacy of albendazole against the larvae of Taenia solium in experimentally infected pigs, and kinetics of the immune response. ( Ganguly, NK; Joshi, K; Kaur, M; Mahajan, RC; Malla, N, 1995) |
| "Intramedullary cysticercosis is a rare manifestation of neurocysticercosis." | 1.29 | Intramedullary cysticercosis cured with drug treatment. A case report. ( Corral, I; Guerrero, A; López-Vélez, R; Martínez-San-Millán, J; Moreno, A; Quereda, C; Sotelo, J, 1996) |
| "After medical treatment of neurocysticercosis, there is usually remission or marked improvement in the associated seizure disorder." | 1.28 | The course of seizures after treatment for cerebral cysticercosis. ( Sotelo, J; Vazquez, V, 1992) |
| "Treatment with praziquantel resulted in the regression of only some of the cysts." | 1.28 | [Selective sensitivity of cysts to praziquantel and albendazole in a case of cerebral cysticercosis]. ( Belec, L; Cohen, L; Pierrot-Deseilligny, C; Sanson, M; Signoret, JL, 1992) |
| " After a single dosage of albendazole 25 mg/kg was taken orally by healthy volunteers and neurocysticercosis patients, sulfoxide and sulfone were found in blood at 20 and 40 min respectively." | 1.28 | [Pharmacokinetics of albendazole and its metabolites in human body]. ( Gong, XY; Guan, TY; Li, MG; Liu, SZ; Sun, WZ; Zheng, LF, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (5.61) | 18.7374 |
| 1990's | 102 (47.66) | 18.2507 |
| 2000's | 42 (19.63) | 29.6817 |
| 2010's | 43 (20.09) | 24.3611 |
| 2020's | 15 (7.01) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, HY | 2 |
| Wang, GX | 1 |
| Xing, YY | 1 |
| Xie, MR | 1 |
| de Andrade Picanço, G | 1 |
| Ferreira de Lima, N | 1 |
| Cristina Gomes, T | 1 |
| de Sousa Mendes Moreira Alves, D | 1 |
| Luísa da Costa, T | 1 |
| Vinaud, MC | 3 |
| Kumar H C, K | 1 |
| Narayana, PS | 1 |
| Kumar, KJ | 1 |
| Wirth, MA | 1 |
| Khan, HM | 1 |
| Sabiq, F | 1 |
| Agoumi, M | 1 |
| Neufeld, A | 1 |
| Özer Balin, Ş | 3 |
| Enez, M | 3 |
| Akbulut, A | 3 |
| Çalık, M | 3 |
| Akgün, B | 3 |
| Balgetir, F | 3 |
| Yıldırım, H | 3 |
| Tao, B | 1 |
| Li, T | 1 |
| Ji, K | 1 |
| Shang, A | 1 |
| Lokdarshi, G | 1 |
| Durgapal, P | 1 |
| Shrestha, R | 1 |
| Shrestha, AK | 1 |
| Francisca, PA | 1 |
| Javier, LF | 1 |
| Guadalupe, PH | 1 |
| Fernanda, GM | 1 |
| Nelly, C | 1 |
| Helgi, JC | 1 |
| Iliana, GH | 1 |
| Susana, RI | 1 |
| Palomares-Alonso, F | 3 |
| Toledo, A | 1 |
| Palencia Hernández, G | 2 |
| Jung-Cook, H | 3 |
| Fleury, A | 1 |
| Haby, MM | 1 |
| Sosa Leon, LA | 1 |
| Luciañez, A | 1 |
| Nicholls, RS | 1 |
| Reveiz, L | 1 |
| Donadeu, M | 1 |
| McCormick, DW | 1 |
| Bacha, JM | 1 |
| El-Mallawany, NK | 1 |
| Kovarik, CL | 1 |
| Slone, JS | 1 |
| Campbell, LR | 1 |
| White, AC | 1 |
| O'Neal, S | 1 |
| Winkler, A | 1 |
| Abraham, A | 1 |
| Carabin, H | 1 |
| Salim, S | 1 |
| Alam, MS | 1 |
| Backiavathy, V | 1 |
| Raichura, ND | 1 |
| Mukherjee, B | 1 |
| Wembulua, BS | 1 |
| Diallo, K | 1 |
| Diallo, M | 1 |
| Dione, MAD | 1 |
| Diop, A | 1 |
| Manga, NM | 1 |
| Moret, E | 1 |
| Borruat, FX | 1 |
| Joob, B | 1 |
| Wiwanitkit, V | 1 |
| Pujari, A | 3 |
| Bajaj, MS | 8 |
| Sen, S | 2 |
| Rakheja, V | 1 |
| Siddiqui, SA | 1 |
| Yadav, RK | 2 |
| Maurya, M | 1 |
| Shrivastava, A | 1 |
| Heller, T | 1 |
| Wallrauch, C | 1 |
| Kaminstein, D | 1 |
| Phiri, S | 1 |
| Ganesh, SK | 1 |
| Surve, A | 1 |
| Goel, S | 1 |
| Mukhija, R | 1 |
| Agarwal, D | 1 |
| Ahmed, S | 1 |
| Paul, SP | 1 |
| Takkar, B | 1 |
| Goel, G | 1 |
| Rathi, A | 1 |
| Dube, M | 1 |
| Nath, S | 1 |
| Prajapati, VK | 1 |
| Pulikkotil, SJ | 1 |
| Kaur, S | 1 |
| Gupta, P | 1 |
| Singh, M | 1 |
| Kiran, S | 1 |
| Goyal, P | 1 |
| Kalra, DK | 1 |
| Rao, A | 1 |
| Simms, A | 1 |
| Pierre-Louis, A | 1 |
| Zou, Y | 1 |
| Wang, F | 1 |
| Wang, HB | 1 |
| Wu, WW | 1 |
| Fan, CK | 1 |
| Wang, L | 1 |
| Tian, XJ | 1 |
| Li, W | 1 |
| Huang, MJ | 1 |
| Szabo, B | 1 |
| Popescu, L | 1 |
| Szabo, I | 1 |
| Opincariu, I | 1 |
| Shoji, H | 1 |
| Hirai, T | 1 |
| Shirakura, T | 1 |
| Takuma, T | 1 |
| Okino, T | 2 |
| Wakatsuki, Y | 1 |
| Niki, Y | 1 |
| Lopes, WD | 1 |
| Cruz, BC | 1 |
| Soares, VE | 1 |
| Nunes, JL | 1 |
| Teixeira, WF | 1 |
| Maciel, WG | 1 |
| Buzzulini, C | 1 |
| Pereira, JC | 1 |
| Felippelli, G | 1 |
| Soccol, VT | 1 |
| de Oliveira, GP | 1 |
| da Costa, AJ | 1 |
| Flammer Anikpeh, Y | 1 |
| Grimm, F | 1 |
| Lindenblatt, N | 1 |
| Zinkernagel, A | 1 |
| Chaudhary, V | 1 |
| Bano, S | 1 |
| Kumar, P | 1 |
| Narula, MK | 1 |
| Anand, R | 1 |
| Tewari, S | 2 |
| Singh, S | 4 |
| Jaiswal, V | 1 |
| Mishra, AK | 2 |
| Van De, N | 1 |
| Le, TH | 1 |
| Lien, PT | 1 |
| Eom, KS | 1 |
| Rojas-Tomé, IS | 1 |
| Pinzón-Estrada, E | 1 |
| Mouhari-Toure, A | 1 |
| N'Timon, B | 1 |
| Kumako, V | 1 |
| Darre, T | 1 |
| Saka, B | 1 |
| Tchaou, M | 1 |
| Amegbor, K | 1 |
| Kombate, K | 1 |
| Balogou, AA | 1 |
| Pitche, P | 1 |
| Ash, A | 3 |
| Okello, A | 1 |
| Khamlome, B | 3 |
| Inthavong, P | 3 |
| Allen, J | 3 |
| Thompson, RCA | 1 |
| Singh, AK | 1 |
| Singh, SK | 1 |
| Singh, A | 2 |
| Gupta, KK | 1 |
| Khatoon, J | 1 |
| Prasad, A | 1 |
| Rai, RP | 1 |
| Gupta, RK | 3 |
| Tripathi, M | 1 |
| Husain, N | 1 |
| Prasad, KN | 1 |
| Gonzalez, AE | 4 |
| Bustos, JA | 1 |
| Garcia, HH | 5 |
| Rodriguez, S | 1 |
| Zimic, M | 1 |
| Castillo, Y | 1 |
| Praet, N | 1 |
| Gabriël, S | 3 |
| Gilman, RH | 4 |
| Dorny, P | 4 |
| Pal, AK | 1 |
| Kumar, R | 1 |
| Khanduri, S | 2 |
| Agrawal, S | 1 |
| Bhadury, S | 1 |
| Sharma, R | 1 |
| Dey, AK | 1 |
| Joshi, K | 2 |
| Thakkar, H | 1 |
| Okello, AL | 2 |
| Thomas, L | 2 |
| Keokamphet, C | 2 |
| Newberry, K | 2 |
| Gauci, CG | 2 |
| Thompson, RA | 2 |
| Lightowlers, MW | 2 |
| Qavi, A | 1 |
| Garg, RK | 4 |
| Malhotra, HS | 1 |
| Jain, A | 1 |
| Kumar, N | 1 |
| Malhotra, KP | 1 |
| Srivastava, PK | 1 |
| Verma, R | 2 |
| Sharma, PK | 1 |
| Mittal, A | 2 |
| Sharma, NS | 1 |
| Sobnach, S | 1 |
| Khosa, SA | 1 |
| Pather, S | 1 |
| Longhurst, S | 1 |
| Kahn, D | 1 |
| Raubenheimer, PJ | 1 |
| Venkatesh, R | 1 |
| Ravindran, RD | 1 |
| Bharathi, B | 1 |
| Sengupta, S | 1 |
| Basu, S | 1 |
| Muthusami, S | 1 |
| Kumar, A | 1 |
| Virk, RS | 1 |
| Panda, N | 1 |
| Ghosh, S | 1 |
| Kumar, S | 4 |
| Handa, A | 1 |
| Chavda, S | 1 |
| Tiwari, R | 1 |
| Abbey, P | 1 |
| Malhotra, R | 1 |
| Garg, P | 1 |
| Mishra, R | 1 |
| Gokarn, A | 1 |
| Gokarn, S | 1 |
| Rathod, V | 1 |
| Chhabra, S | 1 |
| Aggarwal, G | 1 |
| Kalra, R | 1 |
| Duhan, A | 1 |
| Sen, R | 1 |
| Ziaei, M | 1 |
| Elgohary, M | 1 |
| Bremner, FD | 1 |
| Fraga, CM | 2 |
| Costa, TL | 2 |
| Bezerra, JC | 2 |
| de Souza Lino, R | 1 |
| Yanagida, T | 1 |
| Sako, Y | 1 |
| Nakao, M | 1 |
| Nakaya, K | 1 |
| Ito, A | 1 |
| Gupta, DS | 1 |
| Goyal, AK | 1 |
| Tandon, PN | 1 |
| Jurel, SK | 1 |
| Srivastava, S | 1 |
| Dangi, UR | 1 |
| Jain, R | 1 |
| de Souza Lino Junior, R | 1 |
| Jain, S | 2 |
| Kashikar, S | 1 |
| Jaiswal, A | 1 |
| Niakara, A | 1 |
| Cisse, R | 1 |
| Traore, A | 1 |
| Niamba, PA | 1 |
| Barro, F | 1 |
| Kabore, J | 1 |
| Peniche-Cardeña, A | 1 |
| Dominguez-Alpizar, JL | 1 |
| Sima-Alvarez, R | 1 |
| Argaez-Rodriguez, F | 1 |
| Fraser, A | 1 |
| Craig, PS | 1 |
| Rodriguez-Canul, R | 1 |
| Pushker, N | 5 |
| Betharia, SM | 2 |
| Carpio, A | 5 |
| Hauser, WA | 3 |
| Balasubramanya, R | 2 |
| Nash, TE | 1 |
| Horton, J | 4 |
| Chowdhary, A | 1 |
| Bansal, R | 1 |
| Singh, K | 1 |
| Singh, V | 1 |
| Willingham, AL | 1 |
| De, NV | 1 |
| Doanh, NQ | 1 |
| Cong, le D | 1 |
| Dung, TV | 1 |
| Cam, PD | 1 |
| Dalsgaard, A | 1 |
| Puri, P | 2 |
| Grover, AK | 2 |
| Mamere, AE | 1 |
| Muglia, VF | 1 |
| Simão, GN | 1 |
| Belucci, AD | 1 |
| Carlos dos Santos, A | 1 |
| Trad, CS | 1 |
| Takayanagui, OM | 6 |
| Guan, FX | 1 |
| He, ZY | 1 |
| Zhao, MH | 1 |
| Palomares, F | 1 |
| Palencia, G | 2 |
| Pérez, R | 1 |
| González-Esquivel, D | 2 |
| Castro, N | 1 |
| Cook, HJ | 1 |
| Lim, WK | 1 |
| Chee, SP | 1 |
| Sharma, V | 1 |
| Saxena, R | 1 |
| Sharma, P | 3 |
| Sundaram, PM | 1 |
| Jayakumar, N | 1 |
| Noronha, V | 1 |
| Sudan, R | 1 |
| Muralidhar, R | 1 |
| Kalra, V | 2 |
| Seth, R | 1 |
| Mishra, D | 1 |
| Blandón, R | 1 |
| Leandro, IM | 1 |
| Piliado, JC | 1 |
| Ortiz-Plata, A | 1 |
| Epelboin, L | 1 |
| Klement, E | 1 |
| Chemali, N | 1 |
| Danis, M | 1 |
| Bricaire, E | 1 |
| Caumes, E | 1 |
| Goyal, JL | 1 |
| Das, S | 1 |
| Chauhan, D | 1 |
| Baheti, U | 1 |
| Sangit, V | 1 |
| Karande, S | 1 |
| Kumbhare, N | 1 |
| Veena, G | 1 |
| Shon, GM | 1 |
| Usha, K | 1 |
| Nayar, RC | 1 |
| Sethi, PK | 1 |
| Sethi, NK | 1 |
| Torgovnick, J | 1 |
| Arsura, E | 1 |
| Nagaraj, C | 1 |
| Joshi, A | 1 |
| Trikha, V | 1 |
| Reddy, B | 1 |
| Raj, A | 1 |
| Maurya, OP | 1 |
| Bhandary, S | 1 |
| Singh, R | 1 |
| Karki, P | 1 |
| Sinha, AK | 1 |
| Das, D | 1 |
| Iyer, N | 1 |
| Nagaraj, J | 1 |
| Gupta, M | 2 |
| Kassai, T | 1 |
| Takáts, C | 1 |
| Redl, P | 1 |
| Fok, E | 1 |
| Euzéby, J | 1 |
| Geerts, S | 1 |
| Kumar, V | 1 |
| Lopez, MT | 1 |
| Gavidia, C | 1 |
| McDonald, J | 1 |
| Pilcher, JB | 1 |
| Tsang, VC | 2 |
| Santillán, F | 1 |
| León, P | 1 |
| Flores, C | 1 |
| Del Brutto, OH | 15 |
| Quintero, LA | 1 |
| Schmidt, DK | 1 |
| Jordaan, HF | 1 |
| Schneider, JW | 1 |
| Cilliers, J | 1 |
| Martinez, HR | 1 |
| Rangel-Guerra, R | 1 |
| Arredondo-Estrada, JH | 1 |
| Marfil, A | 1 |
| Onofre, J | 1 |
| La Mantia, L | 1 |
| Costa, A | 1 |
| Eoli, M | 1 |
| Savoiardo, M | 1 |
| Ghariani, S | 1 |
| Gille, M | 1 |
| Matthijs, P | 1 |
| Delbecq, J | 1 |
| Depré, A | 1 |
| Agarwal, AK | 1 |
| Dudeja, RK | 1 |
| Chandra, S | 1 |
| Sanchetee, PC | 1 |
| Venkataraman, S | 1 |
| Dhamija, RM | 1 |
| Roy, AK | 1 |
| Chagnon, A | 2 |
| Galzin, M | 1 |
| de Jaureguiberry, JP | 1 |
| Boyer, B | 1 |
| Paris, JF | 2 |
| Marlier, S | 1 |
| Carli, P | 2 |
| Sihota, R | 2 |
| Honavar, SG | 2 |
| Malzacher, VD | 1 |
| Bogumil-Schott, E | 1 |
| Neu, IS | 1 |
| Dharnidharka, VR | 2 |
| Agrawal, M | 1 |
| Dandge, VP | 1 |
| Monteiro, L | 1 |
| Almeida-Pinto, J | 1 |
| Stocker, A | 1 |
| Sampaio-Silva, M | 1 |
| Rajshekhar, V | 3 |
| Botero, D | 1 |
| Tanowitz, HB | 1 |
| Weiss, LM | 1 |
| Wittner, M | 1 |
| Chotmongkol, V | 3 |
| Sotelo, J | 17 |
| Roman, GC | 1 |
| Mukherjee, A | 1 |
| Roy, T | 1 |
| Mukherjee, S | 1 |
| Basu, N | 1 |
| Duttamunshi, A | 1 |
| Bauer, TM | 1 |
| Brühwiler, J | 1 |
| Aschwanden, M | 1 |
| Wagner, S | 1 |
| Schwander, J | 1 |
| Suri, W | 1 |
| St Geme, JW | 1 |
| Maldonado, YA | 1 |
| Enzmann, D | 1 |
| Hotez, PJ | 1 |
| Overturf, GD | 1 |
| Schantz, PM | 1 |
| Sánchez, M | 4 |
| Suástegui, R | 1 |
| Jung, H | 5 |
| Noboa, C | 1 |
| Zhang, Y | 1 |
| Lei, J | 1 |
| Zhang, M | 1 |
| Wan, X | 1 |
| Li, C | 1 |
| Cruz, I | 2 |
| Cruz, ME | 1 |
| Carrasco, F | 1 |
| Raina, UK | 1 |
| Taneja, S | 1 |
| Lamba, PA | 1 |
| Bansal, RL | 1 |
| Thomson, AJ | 1 |
| Maiti, B | 1 |
| Kaur, M | 1 |
| Ganguly, NK | 1 |
| Mahajan, RC | 1 |
| Malla, N | 1 |
| Agapejev, S | 2 |
| Da Silva, MD | 2 |
| Ueda, AK | 1 |
| De Lima Resende, LA | 1 |
| Kar, AM | 1 |
| Corral, I | 1 |
| Quereda, C | 1 |
| Moreno, A | 1 |
| López-Vélez, R | 1 |
| Martínez-San-Millán, J | 1 |
| Guerrero, A | 1 |
| Srivastava, VK | 1 |
| Srivastava, A | 1 |
| Singhal, KC | 1 |
| Maddalena, G | 1 |
| Nozzoli, C | 1 |
| Passarella, B | 1 |
| Whitefield, L | 1 |
| Crowston, JG | 1 |
| Davey, C | 1 |
| Alla, P | 1 |
| Lanchote, VL | 3 |
| Marques, MP | 2 |
| Bonato, PS | 3 |
| Weisse, ME | 1 |
| Raszka, WV | 1 |
| Martinez, M | 1 |
| Herrera, G | 1 |
| Altamirano, J | 1 |
| Cuba, JM | 1 |
| Rios-Saavedra, N | 1 |
| Verastegui, M | 2 |
| Boero, J | 1 |
| Proaño, JV | 1 |
| Madrazo, I | 1 |
| García, L | 1 |
| García-Torres, E | 1 |
| Correa, D | 1 |
| Catacora, M | 1 |
| Chandy, MJ | 1 |
| Sood, AK | 1 |
| Yadav, SP | 1 |
| Malhotra, RC | 1 |
| Chugh, SN | 1 |
| Agarwal, V | 1 |
| Thomas, M | 1 |
| Maheshwari, MC | 1 |
| Sekhar, GC | 2 |
| Lemke, BN | 1 |
| Kohli, A | 1 |
| Gupta, R | 2 |
| Kishore, J | 1 |
| Paias, FO | 2 |
| Manzano-Blanco, S | 1 |
| Gutiérrez-Solana, LG | 1 |
| García-Peñas, JJ | 1 |
| García-Guzmán, P | 1 |
| Ruiz-Falcó, ML | 1 |
| Nag, D | 1 |
| Ko, DY | 1 |
| Chang, GY | 1 |
| Venkatesan, P | 1 |
| Mehta, SS | 1 |
| Hatfield, S | 1 |
| Jessen, L | 1 |
| Vogel, D | 1 |
| de Carvalho, R | 1 |
| Fernández-Gómez, JM | 1 |
| García-Garmendia, JL | 1 |
| López-Domínguez, JM | 1 |
| Casado-Chocán, JL | 1 |
| Escobar, A | 1 |
| Tandon, R | 2 |
| Dada, T | 1 |
| Verma, L | 1 |
| Kitchen, LW | 1 |
| Kathuria, MK | 1 |
| Pradhan, S | 1 |
| Schriever, S | 1 |
| Hasenfratz, G | 1 |
| Hintschich, C | 1 |
| Landau, K | 1 |
| Gupta, S | 2 |
| Jain, VK | 1 |
| Sen, J | 1 |
| Arora, B | 1 |
| Menon, V | 1 |
| Khanna, S | 1 |
| Khokhar, S | 1 |
| Vashisht, S | 1 |
| Garg, I | 1 |
| Pandey, PK | 1 |
| Chaudhuri, Z | 1 |
| Bhatia, A | 1 |
| Lombardo, J | 1 |
| Chandra, M | 1 |
| Takeuchi, T | 1 |
| Lowalekar, KB | 1 |
| Vazquez, V | 1 |
| Silarugs, S | 1 |
| Jardim, E | 1 |
| Aguirre, R | 1 |
| Díaz-Calderón, E | 1 |
| Alarcón, TA | 1 |
| Cohen, L | 1 |
| Belec, L | 1 |
| Sanson, M | 1 |
| Pierrot-Deseilligny, C | 1 |
| Signoret, JL | 1 |
| Placenua, M | 1 |
| Overbosch, D | 1 |
| Hurtado, M | 3 |
| Medina, MT | 3 |
| Puri, V | 1 |
| Sharma, DK | 1 |
| Choudhury, V | 1 |
| Khalil, A | 1 |
| Cruz, M | 1 |
| Davis, LE | 1 |
| Kornfeld, M | 1 |
| Chong, MS | 1 |
| Hawkins, CP | 1 |
| Cook, GC | 1 |
| Hawkes, CH | 1 |
| Kocen, RS | 1 |
| Santoyo, H | 1 |
| Corona, R | 1 |
| Mehndiratta, MM | 1 |
| Jagota, SC | 1 |
| Penagos, P | 5 |
| Escobedo, F | 5 |
| Torres, B | 1 |
| Rodriguez-Carbajal, J | 1 |
| Rubio-Donnadieu, F | 1 |
| Yadav, NV | 1 |
| Guan, TY | 1 |
| Gong, XY | 1 |
| Sun, WZ | 1 |
| Liu, SZ | 2 |
| Zheng, LF | 1 |
| Li, MG | 1 |
| Rodríguez, J | 2 |
| del Bruto, O | 1 |
| Alarcón, F | 1 |
| Escalante, L | 1 |
| Dueñas, G | 1 |
| Montalvo, M | 1 |
| Román, M | 1 |
| Wu, ZD | 1 |
| Quintero-Rodriguez, E | 1 |
| Liu, DH | 1 |
| Zhang, YJ | 1 |
| Li, SS | 1 |
| Lang, ZJ | 1 |
| Wang, YC | 1 |
| Li, FW | 1 |
| Ge, JX | 1 |
| Zhao, JC | 1 |
| Xiao, ZX | 1 |
| Zhao, CY | 1 |
| Liu, YP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Single Dose Treatment With Diethylcarbamazine, Albendazole and Ivermectin in Humans With and Without Wuchereria Bancrofti Infection in Côte d'Ivoire[NCT02845713] | Phase 1 | 66 participants (Actual) | Interventional | 2016-04-17 | Completed | ||
| Comparison of Ivermectin Alone With Albendazole (ALB) Plus Ivermectin (IVM) in Their Efficacy Against Onchocerciasis[NCT03238131] | Phase 3 | 272 participants (Actual) | Interventional | 2012-04-30 | Completed | ||
| Alternative Chemotherapies for Lymphatic Filariasis (LF) Treatment and Elimination in Africa [Cote d'Ivoire][NCT02974049] | 189 participants (Actual) | Interventional | 2015-01-31 | Completed | |||
| A Clinical Trial to Assess the Safety and Efficacy of Moxidectin Combination Treatments vs. Ivermectin Combination Treatments for Bancroftian Filariasis[NCT04410406] | Phase 3 | 164 participants (Actual) | Interventional | 2020-08-20 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
32 reviews available for albendazole and Coenuri Infection
| Article | Year |
|---|---|
Spinal nerve root sleeve cysticercosis: a case report and review of the literature.
Topics: Albendazole; Arachnoid Cysts; Cysticercosis; Female; Humans; Magnetic Resonance Imaging; Middle Aged | 2023 |
Systematic review of the effectiveness of selected drugs for preventive chemotherapy for Taenia solium taeniasis.
Topics: Albendazole; Animals; Anticestodal Agents; Chemoprevention; Cysticercosis; Humans; Niclosamide; Praz | 2020 |
Current status of taeniasis and cysticercosis in Vietnam.
Topics: Albendazole; Animals; Anthelmintics; Antiprotozoal Agents; Cattle; Cattle Diseases; Cysticercosis; F | 2014 |
[Disseminated cysticercosis: report of three cases in Togo].
Topics: Albendazole; Animals; Anthelmintics; Anticonvulsants; Betamethasone; Cysticercosis; Epilepsy; Eye In | 2015 |
Disseminated cysticercosis: clinical spectrum, Toll-like receptor-4 gene polymorphisms and role of albendazole: A prospective follow-up of 60 cases with a review of 56 published cases.
Topics: Adult; Albendazole; Alleles; Animals; Anticestodal Agents; Case-Control Studies; Cysticercosis; Cyst | 2016 |
Orbital cysticercosis, case report and review.
Topics: Albendazole; Animals; Cysticercosis; Cysticercus; Drug Therapy, Combination; Eye Infections, Parasit | 2011 |
Taeniasis and cysticercosis due to Taenia solium in Japan.
Topics: Adult; Albendazole; Animals; Anthelmintics; Cysticercosis; Diatrizoate Meglumine; Female; Humans; In | 2012 |
Platyhelminthes in tongue--a rare case and review.
Topics: Adult; Albendazole; Animals; Anthelmintics; Cysticercosis; Cysticercus; Female; Humans; Swine; Swine | 2012 |
Orbital and adnexal cysticercosis.
Topics: Adult; Albendazole; Antiprotozoal Agents; Child; Child, Preschool; Combined Modality Therapy; Conjun | 2002 |
Human case management and treatment of cysticercosis.
Topics: Adrenal Cortex Hormones; Albendazole; Animals; Case Management; Counseling; Cysticercosis; Cysticerc | 2003 |
Albendazole: a broad spectrum anthelminthic for treatment of individuals and populations.
Topics: Albendazole; Animals; Anthelmintics; Antiprotozoal Agents; Child; Cysticercosis; Echinococcosis; Hel | 2002 |
Albendazole: a broad spectrum anthelminthic for treatment of individuals and populations.
Topics: Albendazole; Animals; Anthelmintics; Antiprotozoal Agents; Child; Cysticercosis; Echinococcosis; Hel | 2002 |
Albendazole: a broad spectrum anthelminthic for treatment of individuals and populations.
Topics: Albendazole; Animals; Anthelmintics; Antiprotozoal Agents; Child; Cysticercosis; Echinococcosis; Hel | 2002 |
Albendazole: a broad spectrum anthelminthic for treatment of individuals and populations.
Topics: Albendazole; Animals; Anthelmintics; Antiprotozoal Agents; Child; Cysticercosis; Echinococcosis; Hel | 2002 |
Albendazole: a broad spectrum anthelminthic for treatment of individuals and populations.
Topics: Albendazole; Animals; Anthelmintics; Antiprotozoal Agents; Child; Cysticercosis; Echinococcosis; Hel | 2002 |
Albendazole: a broad spectrum anthelminthic for treatment of individuals and populations.
Topics: Albendazole; Animals; Anthelmintics; Antiprotozoal Agents; Child; Cysticercosis; Echinococcosis; Hel | 2002 |
Albendazole: a broad spectrum anthelminthic for treatment of individuals and populations.
Topics: Albendazole; Animals; Anthelmintics; Antiprotozoal Agents; Child; Cysticercosis; Echinococcosis; Hel | 2002 |
Albendazole: a broad spectrum anthelminthic for treatment of individuals and populations.
Topics: Albendazole; Animals; Anthelmintics; Antiprotozoal Agents; Child; Cysticercosis; Echinococcosis; Hel | 2002 |
Albendazole: a broad spectrum anthelminthic for treatment of individuals and populations.
Topics: Albendazole; Animals; Anthelmintics; Antiprotozoal Agents; Child; Cysticercosis; Echinococcosis; Hel | 2002 |
Albendazole: a broad spectrum anthelminthic for treatment of individuals and populations.
Topics: Albendazole; Animals; Anthelmintics; Antiprotozoal Agents; Child; Cysticercosis; Echinococcosis; Hel | 2002 |
Albendazole: a broad spectrum anthelminthic for treatment of individuals and populations.
Topics: Albendazole; Animals; Anthelmintics; Antiprotozoal Agents; Child; Cysticercosis; Echinococcosis; Hel | 2002 |
Albendazole: a broad spectrum anthelminthic for treatment of individuals and populations.
Topics: Albendazole; Animals; Anthelmintics; Antiprotozoal Agents; Child; Cysticercosis; Echinococcosis; Hel | 2002 |
Albendazole: a broad spectrum anthelminthic for treatment of individuals and populations.
Topics: Albendazole; Animals; Anthelmintics; Antiprotozoal Agents; Child; Cysticercosis; Echinococcosis; Hel | 2002 |
Albendazole: a broad spectrum anthelminthic for treatment of individuals and populations.
Topics: Albendazole; Animals; Anthelmintics; Antiprotozoal Agents; Child; Cysticercosis; Echinococcosis; Hel | 2002 |
Albendazole: a broad spectrum anthelminthic for treatment of individuals and populations.
Topics: Albendazole; Animals; Anthelmintics; Antiprotozoal Agents; Child; Cysticercosis; Echinococcosis; Hel | 2002 |
Albendazole: a broad spectrum anthelminthic for treatment of individuals and populations.
Topics: Albendazole; Animals; Anthelmintics; Antiprotozoal Agents; Child; Cysticercosis; Echinococcosis; Hel | 2002 |
Current status of cysticercosis in Vietnam.
Topics: Adolescent; Adult; Age Factors; Aged; Albendazole; Animals; Cattle; Communicable Diseases, Emerging; | 2003 |
Optic nerve cysticercosis: case report and review of current management.
Topics: Adult; Albendazole; Anti-Inflammatory Agents; Anticestodal Agents; Cysticercosis; Female; Humans; Op | 2005 |
Extracranial cysticercosis of the parotid gland: a case report with a review of the literature.
Topics: Albendazole; Animals; Anthelmintics; Cysticercosis; Cysticercus; Female; Humans; Magnetic Resonance | 2008 |
[Cerebral cysticercosis treated by albendazole: development of cerebral magnetic resonance imaging].
Topics: Adult; Albendazole; Brain Diseases; Cysticercosis; Epilepsy, Tonic-Clonic; Follow-Up Studies; Humans | 1994 |
Albendazole.
Topics: Albendazole; Cysticercosis; Echinococcosis; Humans; Nervous System Diseases | 1993 |
Active neurocysticercosis, parenchymal and extraparenchymal: a study of 38 patients.
Topics: Adolescent; Adult; Albendazole; Animals; Antibodies, Helminth; Brain Diseases; Cerebrospinal Fluid S | 1993 |
Taeniasis and cysticercosis.
Topics: Adrenal Cortex Hormones; Albendazole; Animals; Brain; Cysticercosis; Humans; Praziquantel; Taeniasis | 1993 |
Therapy for neurocysticercosis: a reappraisal.
Topics: Albendazole; Cysticercosis; Eye Infections, Parasitic; Humans; Nervous System Diseases; Praziquantel | 1993 |
Neurocysticercosis--an update.
Topics: Albendazole; Anthelmintics; Antiplatyhelmintic Agents; Central Nervous System Diseases; Cysticercosi | 1995 |
Cestode infection in children.
Topics: Adolescent; Albendazole; Animals; Anthelmintics; Anticestodal Agents; Antiplatyhelmintic Agents; Ces | 1996 |
Treatment of brain cysticercosis.
Topics: Albendazole; Anthelmintics; Anti-Inflammatory Agents; Brain Diseases; Cysticercosis; Dexamethasone; | 1997 |
Albendazole.
Topics: Albendazole; Animals; Anthelmintics; Antiprotozoal Agents; Cysticercosis; Echinococcosis; Giardiasis | 1998 |
Albendazole versus praziquantel for neurocysticercosis.
Topics: Albendazole; Animals; Anthelmintics; Antiplatyhelmintic Agents; Cysticercosis; Cysticercus; Encephal | 1998 |
Pharmacokinetic optimisation of the treatment of neurocysticercosis.
Topics: Absorption; Albendazole; Animals; Anthelmintics; Biological Availability; Brain Diseases; Cysticerco | 1998 |
Cysticercosis and epilepsy: a critical review.
Topics: Albendazole; Anthelmintics; Antiplatyhelmintic Agents; Brain; Brain Diseases; Clinical Trials as Top | 1998 |
Case studies in international medicine.
Topics: Adolescent; Albendazole; Anti-Infective Agents; Antinematodal Agents; Antiplatyhelmintic Agents; Ant | 1999 |
[Cysticercosis].
Topics: Albendazole; Animals; Anticestodal Agents; Cysticercosis; Diagnosis, Differential; Humans; Prognosis | 2001 |
Optic nerve cysticercosis.
Topics: Adult; Albendazole; Animals; Antibodies, Protozoan; Antiprotozoal Agents; Cysticercosis; Cysticercus | 2002 |
Neurocysticercosis. An introduction with special emphasis on new developments in pharmacotherapy.
Topics: Albendazole; Central Nervous System Diseases; Cimetidine; Cysticercosis; Diagnosis, Differential; Di | 1992 |
Neurocysticercosis: neurologic, pathogenic, diagnostic and therapeutic aspects.
Topics: Albendazole; Animals; Brain Diseases; Cysticercosis; Humans; Magnetic Resonance Imaging; Meninges; P | 1991 |
[Recent developments in the treatment of cysticercosis by traditional Chinese medicine and western medicine].
Topics: Acupuncture Therapy; Adolescent; Adult; Aged; Albendazole; Anthelmintics; Benzimidazoles; Child; Cys | 1985 |
19 trials available for albendazole and Coenuri Infection
| Article | Year |
|---|---|
Treatment of porcine cysticercosis with albendazole.
Topics: Albendazole; Animals; Anthelmintics; Brain; Cysticercosis; Cysticercus; Heart; Meat; Muscle, Skeleta | 1995 |
Is the course of neurocysticercosis modified by treatment with antihelminthic agents?
Topics: Adult; Aged; Albendazole; Anthelmintics; Brain Diseases; Cysticercosis; Drug Therapy, Combination; F | 1995 |
Medical and surgical treatment in neurocysticercosis a magnetic resonance study of 161 cases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albendazole; Brain; Child; Cysticercosis; Female; Humans | 1995 |
Albendazole therapy for neurocysticercosis.
Topics: Adolescent; Adult; Albendazole; Brain Diseases; Child; Cysticercosis; Female; Follow-Up Studies; Hum | 1994 |
Oral albendazole in the management of extraocular cysticercosis.
Topics: Administration, Oral; Adolescent; Adult; Albendazole; Child; Cysticercosis; Eye Infections, Parasiti | 1994 |
Albendazole therapy for persistent, solitary cysticercus granulomas in patients with seizures.
Topics: Adolescent; Adult; Albendazole; Animals; Brain Diseases; Cysticercosis; Cysticercus; Female; Granulo | 1993 |
Pharmacokinetic comparison of two albendazole dosage regimens in patients with neurocysticercosis.
Topics: Adolescent; Adult; Albendazole; Brain Diseases; Cysticercosis; Drug Administration Schedule; Female; | 1993 |
Therapy for neurocysticercosis: pharmacokinetic interaction of albendazole sulfoxide with dexamethasone.
Topics: Adolescent; Adult; Albendazole; Anthelmintics; Anti-Inflammatory Agents; Brain Diseases; Cimetidine; | 1997 |
Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment. Cysticercosis Working Group in Peru.
Topics: Adult; Albendazole; Anthelmintics; Brain Diseases; Cysticercosis; Double-Blind Method; Electroenceph | 1997 |
Albendazole and praziquantel treatment in neurocysticercosis of the fourth ventricle.
Topics: Adult; Albendazole; Anthelmintics; Antiplatyhelmintic Agents; Brain Diseases; Cerebral Ventricles; C | 1997 |
Serologic evolution of neurocysticercosis patients after antiparasitic therapy. Cysticercosis Working Group in Peru.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Anthelmintics; Antibodies, Helminth; Brain; Cysticerc | 1997 |
Validation of diagnostic criteria for solitary cerebral cysticercus granuloma in patients presenting with seizures.
Topics: Albendazole; Anthelmintics; Brain Diseases; Clinical Protocols; Cysticercosis; Diagnosis, Differenti | 1997 |
Enantioselective analysis of albendazole sulfoxide in plasma using the chiral stationary phase.
Topics: Adult; Albendazole; Anthelmintics; Chromatography, High Pressure Liquid; Cysticercosis; Female; Huma | 1997 |
Medical management of orbital myocysticercosis: a pilot study.
Topics: Adolescent; Adult; Albendazole; Anthelmintics; Child; Child, Preschool; Cysticercosis; Eye Infection | 1998 |
Therapy for neurocysticercosis. Comparison between albendazole and praziquantel.
Topics: Adolescent; Adult; Albendazole; Brain Diseases; Cerebrospinal Fluid; Child; Child, Preschool; Cystic | 1992 |
Clinical evaluation of albendazole and praziquantel in the treatment of cerebral cysticercosis.
Topics: Adult; Albendazole; Brain; Brain Diseases; Cysticercosis; Electroencephalography; Female; Follow-Up | 1991 |
Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis.
Topics: Adolescent; Adult; Aged; Albendazole; Brain Diseases; Cysticercosis; Drug Administration Schedule; F | 1990 |
Albendazole therapy for human neurocysticercosis, a controlled study with computerized tomography and magnetic resonance.
Topics: Adolescent; Adult; Albendazole; Brain Diseases; Child; Cysticercosis; Female; Humans; Magnetic Reson | 1989 |
[Clinical observation on the treatment of 300 cases of cysticercosis with albendazole].
Topics: Adolescent; Adult; Aged; Albendazole; Anthelmintics; Benzimidazoles; Child; Child, Preschool; Cystic | 1987 |
163 other studies available for albendazole and Coenuri Infection
| Article | Year |
|---|---|
Case Report: Disseminated Cysticercosis due to Intentional Ingestion of Parasitic Worm Eggs for Weight Loss.
Topics: Albendazole; Animals; Anthelmintics; Brain; Cysticercosis; Female; Humans; Liver; Muscles; Peritoneu | 2021 |
Intraperitoneal and intracranial experimental cysticercosis present different metabolic preferences after treatment with isolated or combined albendazole and nitazoxanide.
Topics: Albendazole; Animals; Cysticercosis; Cysticercus; Mice; Mice, Inbred BALB C; Nitro Compounds; Taenia | 2022 |
Isolated Intramuscular Cysticercosis in Children: A Case Report
Topics: Albendazole; Animals; Biopsy, Fine-Needle; Child; Cysticercosis; Humans; Taenia solium; Ultrasonogra | 2022 |
Metastatic neuroendocrine tumor masquerading as orbital cysticercosis.
Topics: Adult; Albendazole; Cysticercosis; Exophthalmos; Female; Humans; Neuroendocrine Tumors; Orbital Neop | 2023 |
[A Histopathologically Diagnosed Neurocysticercosis Case from Türkiye].
Topics: Albendazole; Animals; Brain; Cysticercosis; Cysts; Humans; Neurocysticercosis; Swine | 2022 |
[A Histopathologically Diagnosed Neurocysticercosis Case from Türkiye].
Topics: Albendazole; Animals; Brain; Cysticercosis; Cysts; Humans; Neurocysticercosis; Swine | 2022 |
[A Histopathologically Diagnosed Neurocysticercosis Case from Türkiye].
Topics: Albendazole; Animals; Brain; Cysticercosis; Cysts; Humans; Neurocysticercosis; Swine | 2022 |
[A Histopathologically Diagnosed Neurocysticercosis Case from Türkiye].
Topics: Albendazole; Animals; Brain; Cysticercosis; Cysts; Humans; Neurocysticercosis; Swine | 2022 |
Case Report: Three-Day Albendazole Regimen for Orbital Cysticercosis and the Stardust Sign.
Topics: Albendazole; Cysticercosis; Eye Infections, Parasitic; Humans; Orbital Diseases; Tomography, X-Ray C | 2023 |
Disseminated neurocysticercosis with bilateral papilledema: a case report.
Topics: Albendazole; Antiprotozoal Agents; Cysticercosis; Dexamethasone; Glucocorticoids; Humans; Male; Neur | 2019 |
Cysticidal activity of praziquantel-mebendazole combination: In vitro and in vivo studies.
Topics: Albendazole; Animals; Anthelmintics; Blood-Brain Barrier; Cysticercosis; Drug Combinations; Mebendaz | 2020 |
Effect of dexamethasone on albendazole cysticidal activity in experimental cysticercosis by Taenia crassiceps in BALB/c mice: In vitro and in vivo evaluation.
Topics: Albendazole; Animals; Anthelmintics; Anti-Inflammatory Agents; Cysticercosis; Dexamethasone; Drug In | 2020 |
Disseminated cysticercosis and Kaposi sarcoma in a child with HIV/AIDS: A case report.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Albendazole; Animals; Ant | 2020 |
The data are inadequate to assess safety and efficacy of mass chemotherapy for Taenia solium taeniasis.
Topics: Albendazole; Animals; Cysticercosis; Praziquantel; Taenia solium; Taeniasis | 2020 |
Orbital cysticercosis: clinical features and management outcomes.
Topics: Adult; Albendazole; Cysticercosis; Eye Infections, Parasitic; Female; Humans; Male; Middle Aged; Ocu | 2021 |
[Disseminated cysticercosis affecting the brain, the eye and the skin on a Senegalese patient].
Topics: Aged; Albendazole; Brain; Cysticercosis; Diagnosis, Differential; Eye; Eye Infections, Parasitic; Fe | 2020 |
Painful Recurrent Diplopia Caused by Medial Rectus Cysticercosis.
Topics: Adolescent; Albendazole; Anthelmintics; Anti-Inflammatory Agents; Cysticercosis; Diplopia; Female; H | 2021 |
Isolated Myocysticercosis.
Topics: Albendazole; Cysticercosis; Humans | 2017 |
Cysticercosis of the eyelid.
Topics: Adult; Albendazole; Animals; Anthelmintics; Anti-Inflammatory Agents; Biopsy; Cysticercosis; Cystice | 2017 |
Isolated adductor myocysticercosis in a 6-year-old girl.
Topics: Albendazole; Anthelmintics; Child; Cysticercosis; Diagnosis, Differential; Female; Humans; Muscle, S | 2017 |
Case Report: Cysticercosis: Sonographic Diagnosis of a Treatable Cause of Epilepsy and Skin Nodules.
Topics: Adult; Albendazole; Animals; Brain; Cysticercosis; Epilepsy; Female; Humans; Muscle, Skeletal; Prazi | 2017 |
Analysis of Clinical Profile, Investigation, and Management of Ocular Cysticercosis Seen at a Tertiary Referral Centre.
Topics: Adolescent; Adult; Albendazole; Animals; Antibodies, Helminth; Anticestodal Agents; Child; Child, Pr | 2018 |
Extraocular muscle cysticercosis: never skip steroids.
Topics: Adolescent; Albendazole; Anthelmintics; Anti-Inflammatory Agents; Cysticercosis; Diagnosis, Differen | 2018 |
Orbital cysticercosis.
Topics: Adult; Albendazole; Antiprotozoal Agents; Cysticercosis; Diagnosis, Differential; Diplopia; Endemic | 2018 |
Extra-Ocular Cysticercosis Mimicking Orbital Cellulitis.
Topics: Adolescent; Albendazole; Animals; Anthelmintics; Cysticercosis; Diagnosis, Differential; Enzyme-Link | 2018 |
Atypical histopathology findings in presumed epibulbar cysticercosis.
Topics: Adult; Albendazole; Anthelmintics; Biopsy; Cysticercosis; Diagnosis, Differential; Eye; Eye Infectio | 2018 |
Myocysticercosis of the Masseter Muscle.
Topics: Albendazole; Cysticercosis; Follow-Up Studies; Humans; Jaw; Jaw Diseases; Male; Masseter Muscle; Mus | 2019 |
Cysticercosis of the superior oblique muscle of the eye.
Topics: Adult; Albendazole; Animals; Antiprotozoal Agents; Cysticercosis; Diplopia; Eye Infections, Parasiti | 2019 |
Isolated cardiac cysticercosis: treatment with or without steroids?
Topics: Adult; Albendazole; Anthelmintics; Cysticercosis; Heart Diseases; Humans; Male; Steroids | 2019 |
Disseminated cysticercosis in China with complex and variable clinical manifestations: a case series.
Topics: Adolescent; Adult; Albendazole; Animals; Antibodies; Antiprotozoal Agents; Brain; Cysticercosis; Fem | 2019 |
[Diagnosis of orbital cysticercosis -- a challenge for ophthalmologist].
Topics: Adult; Albendazole; Anticestodal Agents; Contrast Media; Cysticercosis; Diplopia; Female; Humans; Ma | 2012 |
[A case of cysticercosis with multiple lesions in the brain and femoral muscles].
Topics: Adult; Albendazole; Brain; Cysticercosis; Drug Therapy, Combination; Humans; Male; Muscle, Skeletal; | 2013 |
Historic of therapeutic efficacy of albendazol sulphoxide administered in different routes, dosages and treatment schemes, against Taenia saginata cysticercus in cattle experimentally infected.
Topics: Administration, Oral; Albendazole; Animals; Anticestodal Agents; Cattle; Cattle Diseases; Cysticerco | 2014 |
It isn't always caviar.
Topics: Albendazole; Animals; Anthelmintics; Cysticercosis; Debridement; Diagnosis, Differential; Fasciitis, | 2014 |
Hepatic cysticercosis: a rare entity.
Topics: Adrenal Cortex Hormones; Adult; Albendazole; Anthelmintics; Cysticercosis; Diagnosis, Differential; | 2014 |
Myoparasitism mimicking parotid swelling: a rare presentation of cysticercosis.
Topics: Adult; Albendazole; Cysticercosis; Diagnosis, Differential; Edema; Follow-Up Studies; Humans; Male; | 2014 |
Murine cysticercosis model: influence of the infection time and the time of treatment on the cysticidal efficacy of albendazole and praziquantel.
Topics: Albendazole; Animals; Anthelmintics; Cysticercosis; Cysticercus; Disease Models, Animal; Drug Admini | 2015 |
Controlling Taenia solium and soil transmitted helminths in a northern Lao PDR village: Impact of a triple dose albendazole regime.
Topics: Albendazole; Ancylostomatoidea; Animals; Anthelmintics; Ascariasis; Ascaris lumbricoides; Cysticerco | 2017 |
Immune response to Taenia solium cysticerci after anti-parasitic therapy.
Topics: Albendazole; Animals; Anti-Inflammatory Agents; Antiparasitic Agents; Brain; Cysticercosis; Cysticer | 2015 |
Successful Antiparasitic Treatment for Cysticercosis is Associated with a Fast and Marked Reduction of Circulating Antigen Levels in a Naturally Infected Pig Model.
Topics: Albendazole; Animals; Anticestodal Agents; Antigens, Helminth; Benzimidazoles; Cysticercosis; Diseas | 2015 |
Isolated mammary cysticercosis.
Topics: Adult; Albendazole; Anthelmintics; Breast; Cysticercosis; Female; Humans; India; Ultrasonography, Ma | 2015 |
A rare case of isolated cysticercus involvement of inferior rectus muscle presenting with upward gaze restriction.
Topics: Adolescent; Albendazole; Animals; Anticestodal Agents; Cysticercosis; Cysticercus; Eye Infections, P | 2016 |
Ocular cysticercosis with intermittent blindness.
Topics: Adolescent; Albendazole; Anthelmintics; Blindness; Cysticercosis; Eye Infections, Parasitic; Humans; | 2015 |
Assessing the impact of a joint human-porcine intervention package for Taenia solium control: Results of a pilot study from northern Lao PDR.
Topics: Adult; Aged; Aged, 80 and over; Albendazole; Animals; Anthelmintics; Benzimidazoles; Cysticercosis; | 2016 |
Reprint of "Assessing the impact of a joint human-porcine intervention package for Taenia solium control: Results of a pilot study from northern Lao PDR".
Topics: Albendazole; Animals; Anthelmintics; Cysticercosis; Enzyme-Linked Immunosorbent Assay; Feces; Humans | 2017 |
Psoas muscle cysticercosis presenting as acute appendicitis.
Topics: Acute Disease; Albendazole; Animals; Anticestodal Agents; Appendicitis; Cysticercosis; Cysticercus; | 2008 |
First case report of pharyngeal cysticercosis.
Topics: Aged, 80 and over; Albendazole; Animals; Anthelmintics; Cysticercosis; Diagnosis, Differential; Fema | 2009 |
Optic nerve cysticercosis.
Topics: Adult; Albendazole; Animals; Antibodies, Helminth; Antiprotozoal Agents; Cysticercosis; Cysticercus; | 2008 |
Ocular cysticercosis: an unusual cause of ptosis.
Topics: Albendazole; Animals; Blepharoptosis; Child; Cysticercosis; Cysticercus; Enzyme-Linked Immunosorbent | 2009 |
Mylohyoid cysticercosis: a rare submandibular mass.
Topics: Adult; Albendazole; Animals; Antiprotozoal Agents; Cysticercosis; Female; Humans; Neck Muscles; Subm | 2009 |
Intramedullary cysticercosis.
Topics: Albendazole; Anthelmintics; Cysticercosis; Female; Humans; Laminectomy; Magnetic Resonance Imaging; | 2010 |
Orbital cysticercosis: masquerading as orbital inflammatory disorder.
Topics: Albendazole; Animals; Anti-Inflammatory Agents; Anticestodal Agents; Child; Cysticercosis; Cysticerc | 2011 |
Ultrasonography for masseter muscle cysticercosis.
Topics: Albendazole; Anti-Inflammatory Agents; Anticestodal Agents; Child; Cysticercosis; Female; Humans; Ma | 2011 |
Oral cysticercosis-a rare presentation.
Topics: Albendazole; Antiprotozoal Agents; Biopsy, Fine-Needle; Child; Cysticercosis; Female; Humans; Lip; T | 2011 |
Taenia crassiceps: host treatment alters glycolisis and tricarboxilic acid cycle in cysticerci.
Topics: Albendazole; Animals; Anthelmintics; Citric Acid Cycle; Cysticercosis; Cysticercus; Energy Metabolis | 2012 |
Fatty acids oxidation and alternative energy sources detected in Taenia crassiceps cysticerci after host treatment with antihelminthic drugs.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Albendazole; Animals; Anthelmintics; Creatinine; Cysticercosis | 2012 |
Herculean appearance due to disseminated cysticercosis: case report.
Topics: Albendazole; Anticestodal Agents; Brain; Cysticercosis; Humans; Hypertrophy; Magnetic Resonance Imag | 2012 |
Multiple brain parenchymal neurocysticercosis with extraocular muscle cysticercosis affecting levator palpebral superioris and superior rectus complex: an unusual association.
Topics: Albendazole; Anti-Inflammatory Agents; Anticestodal Agents; Blepharoptosis; Brain Diseases; Child; C | 2013 |
[Myocardial localization of a disseminated cysticercosis. Echocardiographic diagnosis of a case].
Topics: Adult; Albendazole; Anthelmintics; Cysticercosis; Echocardiography; Heart; Humans; Male; Treatment O | 2002 |
Chemotherapy of porcine cysticercosis with albendazole sulphoxide.
Topics: Albendazole; Animals; Anticestodal Agents; Brain; Cysticercosis; Dose-Response Relationship, Drug; F | 2002 |
Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis.
Topics: Adolescent; Adult; Aged; Albendazole; Anthelmintics; Anti-Inflammatory Agents; Child; Child, Prescho | 2002 |
Cysticercosis of superior oblique muscle: surgical excision and reconstruction of superior oblique tendon.
Topics: Albendazole; Animals; Antiprotozoal Agents; Child; Cysticercosis; Cysticercus; Drug Therapy, Combina | 2002 |
Ocular cysticercosis--a profile.
Topics: Adolescent; Adult; Albendazole; Animals; Anthelmintics; Child; Combined Modality Therapy; Cysticerco | 2003 |
Regression of orbital myocysticercosis: an ultrasonographic study.
Topics: Adolescent; Adult; Albendazole; Anticestodal Agents; Child; Child, Preschool; Cysticercosis; Eye Inf | 2001 |
Disseminated cysticercosis with pulmonary involvement.
Topics: Albendazole; Anthelmintics; Brain; Cysticercosis; Diagnosis, Differential; Humans; Lung; Magnetic Re | 2004 |
[Clinical observation of 7,126 cases of cysticercosis treated with albendazole].
Topics: Adolescent; Adult; Aged; Albendazole; Anticestodal Agents; Child; Child, Preschool; Cysticercosis; F | 2003 |
In vitro effects of albendazole sulfoxide and praziquantel against Taenia solium and Taenia crassiceps cysts.
Topics: Albendazole; Animals; Anthelmintics; Antiplatyhelmintic Agents; Cysticercosis; Humans; Male; Mice; M | 2004 |
Nonsurgical management of subretinal cysticercosis.
Topics: Albendazole; Antiprotozoal Agents; Cysticercosis; Drug Therapy, Combination; Eye Infections, Parasit | 2004 |
Myocysticercosis: a cause of acquired ptosis in children simulating congenital ptosis with lid lag (report of two cases).
Topics: Albendazole; Antiprotozoal Agents; Blepharoptosis; Child, Preschool; Cysticercosis; Diagnosis, Diffe | 2004 |
Extraocular muscle cysticercosis - a clinical challenge to the ophthalmologists.
Topics: Adolescent; Adult; Albendazole; Antiprotozoal Agents; Child; Child, Preschool; Cysticercosis; Diplop | 2004 |
Disseminated cysticercosis involving orbit, brain and subcutaneous tissue.
Topics: Albendazole; Anti-Inflammatory Agents; Anticestodal Agents; Cysticercosis; Female; Humans; Magnetic | 2005 |
Extraneural cysticercosis - presenting as painless cervical swellings.
Topics: Albendazole; Anticestodal Agents; Child; Cysticercosis; Diagnosis, Differential; Humans | 2006 |
[Human cardiac cysticercosis].
Topics: Albendazole; Anthelmintics; Cardiomyopathies; Cysticercosis; Echocardiography, Doppler; Humans; Male | 2002 |
Efficacy of nitazoxanide, tizoxanide and tizoxanide/albendazole sulphoxide combination against Taenia crassiceps cysts.
Topics: Albendazole; Animals; Anticestodal Agents; Cysticercosis; Drug Combinations; Drug Synergism; Mice; M | 2007 |
[Neurocysticercosis complicating the treatment of cutaneous cysticercosis in a traveller].
Topics: Adult; Albendazole; Anthelmintics; Brain Edema; Combined Modality Therapy; Confusion; Cysticercosis; | 2004 |
Retrobulbar cysticercosis masquerading as optic nerve glioma.
Topics: Albendazole; Anthelmintics; Child; Cysticercosis; Diagnosis, Differential; Drug Therapy, Combination | 2007 |
Simultaneous brain and ocular cysticercosis in a five-year-old boy.
Topics: Albendazole; Anthelmintics; Anti-Inflammatory Agents; Child, Preschool; Cysticercosis; Eye Infection | 2007 |
Cysticercosis of temporalis muscle: an unusual cause of temporal headaches. A case report.
Topics: Adult; Albendazole; Anthelmintics; Cysticercosis; Diagnosis, Differential; Enzyme-Linked Immunosorbe | 2007 |
Cysticercosis of biceps brachii: a rare cause of posterior interosseous nerve syndrome.
Topics: Adolescent; Albendazole; Animals; Anthelmintics; Cysticercosis; Forearm; Humans; Magnetic Resonance | 2008 |
Spontaneous extrusion of subconjunctival cysticercosis.
Topics: Albendazole; Anthelmintics; Child; Conjunctival Diseases; Cysticercosis; Eye Infections, Parasitic; | 2007 |
Cysticercosis of tongue--diagnostic dilemma.
Topics: Albendazole; Animals; Anthelmintics; Child, Preschool; Cysticercosis; Female; Humans; Meat; Nepal; S | 2004 |
Masseter cysticercosis - a rare case diagnosed on ultrasound.
Topics: Albendazole; Anthelmintics; Cysticercosis; Dexamethasone; Glucocorticoids; Humans; Male; Masseter Mu | 2008 |
Treatment of taenia with albendazole.
Topics: Albendazole; Animals; Anthelmintics; Benzimidazoles; Cattle; Cattle Diseases; Cysticercosis | 1984 |
[Preventive and curative efficacy of a albendazole in hepatico-peritoneal cysticercosis in rabbit. A laboratory model for chemotherapy of hydatidosis (author's transl)].
Topics: Albendazole; Animals; Anthelmintics; Benzimidazoles; Cysticercosis; Disease Models, Animal; Echinoco | 1981 |
Effect of albendazole on Taenia saginata.
Topics: Albendazole; Animals; Anthelmintics; Benzimidazoles; Cattle; Cattle Diseases; Cysticercosis | 1981 |
Cysticercosis mimicking brain tumor: the role of albendazole as a diagnostic tool.
Topics: Albendazole; Anthelmintics; Brain Diseases; Brain Neoplasms; Cysticercosis; Diagnosis, Differential; | 1995 |
Cerebral and subcutaneous cysticercosis treated with albendazole.
Topics: Adult; Albendazole; Anthelmintics; Antiparasitic Agents; Brain Diseases; Cysticercosis; Humans; Male | 1995 |
Solitary cysticercus granulomas.
Topics: Albendazole; Animals; Brain Diseases; Cysticercosis; Granuloma; Humans; Seizures; Tomography, X-Ray | 1995 |
Racemose neurocysticercosis after chronic meningitis: effect of medical treatment.
Topics: Adult; Albendazole; Chronic Disease; Cysticercosis; Follow-Up Studies; Humans; Magnetic Resonance Im | 1995 |
Medical treatment of cysticercosis--effective.
Topics: Albendazole; Cysticercosis; Humans; Nervous System Diseases; Praziquantel | 1995 |
Advances in treatment of neurocysticercosis.
Topics: Albendazole; Brain Diseases; Controlled Clinical Trials as Topic; Cysticercosis; Drug Administration | 1994 |
[Prolonged treatment of recurrent neurocysticercosis using sequential doses of albendazole and praziquantel].
Topics: Adult; Albendazole; Brain Diseases; Cysticercosis; Drug Administration Schedule; Drug Therapy, Combi | 1994 |
Prognostic factors for seizure recurrence after withdrawal of antiepileptic drugs in patients with neurocysticercosis.
Topics: Adolescent; Adult; Albendazole; Brain Diseases; Child; Cysticercosis; Epilepsy; Female; Humans; Male | 1994 |
[Intraspinal manifestation of cysticercosis--Cysticercus racemosus. A case report and review of the literature].
Topics: Albendazole; Animals; Antibodies, Helminth; Cysticercosis; Cysticercus; Female; Humans; Lumbar Verte | 1994 |
Cysticercus granuloma.
Topics: Albendazole; Cysticercosis; Granuloma; Humans; Time Factors; Tomography, X-Ray Computed | 1994 |
Treatment of neurocysticercosis with a two week course of albendazole.
Topics: Adolescent; Adult; Albendazole; Brain Diseases; Cysticercosis; Drug Administration Schedule; Epileps | 1993 |
Neurocysticercosis.
Topics: Adolescent; Adult; Albendazole; Antibodies, Helminth; Child; Child, Preschool; Cysticercosis; Enzyme | 1993 |
[Neurocysticercosis].
Topics: Albendazole; Animals; Antibodies, Helminth; Brain; Brain Diseases; Croatia; Cysticercosis; Diagnosis | 1994 |
Neurocysticercosis.
Topics: Albendazole; Brain Diseases; Child; Cysticercosis; Humans; India; Magnetic Resonance Imaging; Tomogr | 1994 |
Consensus: diagnosis and management of neurocysticercosis in children.
Topics: Adult; Albendazole; Brain; Central Nervous System Diseases; Child; Cysticercosis; Dexamethasone; Fec | 1993 |
Case 8-1993: cysticercosis.
Topics: Albendazole; Brain Diseases; Cysticercosis; Humans; Praziquantel; Subarachnoid Space | 1993 |
The use of albendazole in patients with single lesions enhanced on contrast CT.
Topics: Albendazole; Brain Diseases; Brain Neoplasms; Cysticercosis; Humans; Tomography, X-Ray Computed | 1993 |
Albendazole--newer therapy for neurocysticercosis.
Topics: Albendazole; Brain Diseases; Cysticercosis; Dexamethasone; Drug Therapy, Combination; Humans | 1993 |
Albendazole therapy for giant subarachnoid cysticerci.
Topics: Adult; Albendazole; Brain Diseases; Cysticercosis; Dexamethasone; Female; Humans; Subarachnoid Space | 1993 |
[Observation on dynamics of circulating antigen from patients with cysticercosis before and after treatment].
Topics: Albendazole; Animals; Anticestodal Agents; Antigens, Helminth; Cysticercosis; Humans | 1995 |
Neurocysticercosis: optimal dose treatment with albendazole.
Topics: Adult; Albendazole; Analysis of Variance; Anthelmintics; Brain Diseases; Cysticercosis; Dose-Respons | 1995 |
Spontaneous extrusion of extraocular cysticercus cysts.
Topics: Adult; Albendazole; Animals; Anthelmintics; Anti-Inflammatory Agents; Child; Conjunctiva; Conjunctiv | 1996 |
Therapy with parasiticidal drugs in cysticercal encephalitis--is it indicated?
Topics: Albendazole; Animals; Anthelmintics; Antiplatyhelmintic Agents; Child, Preschool; Cysticercosis; Enc | 1996 |
Evaluation of the efficacy of albendazole against the larvae of Taenia solium in experimentally infected pigs, and kinetics of the immune response.
Topics: Albendazole; Animals; Anthelmintics; Antibodies, Helminth; Antigens, Helminth; Cysticercosis; Cystic | 1995 |
Severe forms of neurocysticercosis: treatment with albendazole.
Topics: Adolescent; Adult; Albendazole; Anthelmintics; Brain Diseases; Chlorpheniramine; Cysticercosis; Fema | 1996 |
[Polyradiculoneuritis and neurocysticercosis: report of a case].
Topics: Adult; Albendazole; Anthelmintics; Central Nervous System Diseases; Cysticercosis; Humans; Male; Pol | 1996 |
Failure of albendazole therapy in two common types of parenchymal neurocysticercosis.
Topics: Adult; Albendazole; Anthelmintics; Brain; Brain Diseases; Cysticercosis; Humans; Male; Tomography, X | 1995 |
Intramedullary cysticercosis cured with drug treatment. A case report.
Topics: Adult; Albendazole; Anthelmintics; Cysticercosis; Dexamethasone; Female; Follow-Up Studies; Humans; | 1996 |
Albendazole therapy in orbital cysticercosis.
Topics: Adult; Albendazole; Anthelmintics; Cysticercosis; Female; Humans; Orbital Diseases; Tomography, X-Ra | 1996 |
Neurocysticercosis treated with albendazole long term follow-up of a case.
Topics: Albendazole; Brain Diseases; Cysticercosis; Humans; Magnetic Resonance Imaging; Male; Middle Aged; T | 1995 |
Cavernous sinus syndrome associated with neurocysticercosis.
Topics: Adult; Albendazole; Brain Diseases; Cavernous Sinus; Cysticercosis; Frontal Lobe; Humans; Male; Pred | 1996 |
[Results of sequential prolonged courses of albendazole and praziquantel in recurrent neurocysticercosis].
Topics: Adult; Albendazole; Anthelmintics; Brain Diseases; Cysticercosis; Drug Therapy, Combination; Humans; | 1996 |
Albendazole therapy for subarachnoid cysticerci: clinical and neuroimaging analysis of 17 patients.
Topics: Adult; Aged; Albendazole; Anthelmintics; Cysticercosis; Female; Humans; Male; Middle Aged; Subarachn | 1997 |
Neurocysticercosis--an unusual presentation.
Topics: Adult; Albendazole; Anthelmintics; Cysticercosis; Humans; Male; Neurocognitive Disorders | 1995 |
Intramedullary cysticerci.
Topics: Adult; Albendazole; Anthelmintics; Cysticercosis; Enzyme-Linked Immunosorbent Assay; Humans; Magneti | 1995 |
Orbital cysticercosis.
Topics: Adolescent; Adult; Albendazole; Animals; Anthelmintics; Child; Child, Preschool; Conjunctiva; Conjun | 1997 |
Anterior cerebral artery territory infarction in neurocysticercosis: evaluation by MR angiography and in vivo proton MR spectroscopy.
Topics: Albendazole; Anthelmintics; Cerebral Arteries; Cerebral Infarction; Child; Contraindications; Cystic | 1997 |
[A case of mixed (parenchymatous meningo-basal) neurocysticercosis].
Topics: Albendazole; Anthelmintics; Anti-Inflammatory Agents; Brain Diseases; Calcinosis; Child; Cysticercos | 1997 |
Intramedullary spinal cysticercosis: response to albendazole: case reports and review of literature.
Topics: Albendazole; Anthelmintics; Child; Cysticercosis; Humans; Magnetic Resonance Imaging; Male; Radionuc | 1998 |
[Neurocysticercosis in children: clinical and radiological analysis and prognostic factors in 54 patients].
Topics: Adolescent; Albendazole; Anthelmintics; Anticonvulsants; Brain; Brain Diseases; Carbamazepine; Child | 1997 |
Albendazole therapy for neurocysticercosis.
Topics: Albendazole; Anthelmintics; Brain Diseases; Cysticercosis; Humans | 1998 |
Albendazole therapy for neurocysticercosis.
Topics: Albendazole; Anthelmintics; Brain Diseases; Cysticercosis; Humans | 1998 |
Simultaneous determination of albendazole sulfoxide enantiomers and albendazole sulfone in plasma.
Topics: Albendazole; Antiparasitic Agents; Chromatography, High Pressure Liquid; Cysticercosis; Humans; Repr | 1998 |
[Neurocysticercosis and convulsive crises].
Topics: Adult; Albendazole; Animals; Anthelmintics; Antibodies, Helminth; Anticonvulsants; Calcinosis; Cysti | 1998 |
Incidence and significance of adverse effects of albendazole therapy in patients with a persistent solitary cysticercus granuloma.
Topics: Adolescent; Adult; Albendazole; Anthelmintics; Child; Child, Preschool; Cysticercosis; Female; Granu | 1998 |
Optic neuritis following albendazole therapy for orbital cysticercosis.
Topics: Administration, Oral; Adult; Albendazole; Animals; Antibodies, Helminth; Anticestodal Agents; Cystic | 1998 |
Albendazole therapy for subarachnoid cysticerci: clinical and neuroimaging analysis of 17 patients.
Topics: Albendazole; Anthelmintics; Cysticercosis; Humans; Subarachnoid Space; Tomography, X-Ray Computed | 1999 |
Magnetisation transfer magnetic resonance imaging demonstration of perilesional gliosis--relation with epilepsy in treated or healed neurocysticercosis.
Topics: Adult; Albendazole; Anticonvulsants; Calcinosis; Cysticercosis; Epilepsy, Complex Partial; Female; F | 1999 |
Heavy nonencephalitic cerebral cysticercosis in tapeworm carriers. The Cysticercosis Working Group in Perú.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Albendazole; Animals; Anthelmintics; Brain Diseases; Car | 1999 |
Myocysticercosis: experience with imaging and therapy.
Topics: Administration, Oral; Adolescent; Adult; Albendazole; Anti-Inflammatory Agents; Antiprotozoal Agents | 1999 |
[Enlargement of an extraocular eye muscle: a symptom of cysticercosis].
Topics: Adrenal Cortex Hormones; Adult; Albendazole; Anticestodal Agents; Cysticercosis; Diagnosis, Differen | 1999 |
Subcutaneous cysticercosis involving the eyelid: sonographic diagnosis.
Topics: Adolescent; Adult; Albendazole; Anthelmintics; Antiparasitic Agents; Cysticercosis; Eye Infections, | 2000 |
Cysticercosis of the optic nerve.
Topics: Albendazole; Animals; Anthelmintics; Anti-Inflammatory Agents; Cysticercosis; Cysticercus; Eye Infec | 2000 |
Extraocular muscle cysticercosis presenting as Brown syndrome.
Topics: Adult; Albendazole; Antiprotozoal Agents; Cysticercosis; Drug Therapy, Combination; Eye Infections, | 2001 |
Subretinal cysticercosis.
Topics: Adult; Albendazole; Animals; Anti-Inflammatory Agents; Antiprotozoal Agents; Cysticercosis; Drug The | 2001 |
Ocular and orbital cysticercosis.
Topics: Adolescent; Adult; Albendazole; Antiprotozoal Agents; Child; Combined Modality Therapy; Cysticercosi | 2001 |
Albendazole therapy in ring lesions of neurocysticercosis.
Topics: Adolescent; Albendazole; Brain Diseases; Child; Cysticercosis; Diagnosis, Differential; Humans; Male | 1992 |
Albendazole treatment of neurocysticercosis.
Topics: Adolescent; Adult; Albendazole; Brain Diseases; Cysticercosis; Female; Follow-Up Studies; Humans; Ma | 1992 |
The course of seizures after treatment for cerebral cysticercosis.
Topics: Adult; Albendazole; Brain; Brain Diseases; Cysticercosis; Epilepsy; Female; Follow-Up Studies; Human | 1992 |
Transient paralytic attacks with cerebral cysticercosis.
Topics: Adult; Albendazole; Brain Diseases; Cysticercosis; Drug Therapy, Combination; Epilepsy, Tonic-Clonic | 1992 |
Albendazole therapy for giant subarachnoid cysticerci.
Topics: Adult; Albendazole; Brain Diseases; Cysticercosis; Humans; Male; Middle Aged; Subarachnoid Space; To | 1992 |
[Selective sensitivity of cysts to praziquantel and albendazole in a case of cerebral cysticercosis].
Topics: Adult; Albendazole; Brain Diseases; Cysticercosis; Drug Resistance; Drug Therapy, Combination; Follo | 1992 |
Definition of contemporary surgical management in cisternal and parenchymatous cysticercosis cerebri.
Topics: Albendazole; Cysticercosis; Follow-Up Studies; Humans; Neurologic Examination; Praziquantel; Tomogra | 1992 |
Clinical pharmacokinetics of albendazole in patients with brain cysticercosis.
Topics: Administration, Oral; Adult; Aged; Albendazole; Anthelmintics; Brain Diseases; Cysticercosis; Female | 1992 |
Neurocysticercosis in children.
Topics: Adolescent; Albendazole; Brain Diseases; Child; Child, Preschool; Cysticercosis; Drug Therapy, Combi | 1991 |
A resistant case of neurocystercercosis.
Topics: Adult; Albendazole; Brain Diseases; Cysticercosis; Drug Resistance; Drug Therapy, Combination; Femal | 1991 |
Total recovery of visual function after treatment for cerebral cysticercosis.
Topics: Adult; Albendazole; Brain Diseases; Cysticercosis; Female; Humans; Vision, Ocular; Visual Acuity; Vi | 1991 |
Neurocysticercosis.
Topics: Albendazole; Brain Diseases; Cysticercosis; Humans; Praziquantel | 1990 |
Neurocysticercosis.
Topics: Albendazole; Brain Diseases; Cysticercosis; Drug Administration Schedule; Humans; Praziquantel | 1990 |
Dexamethasone increases plasma levels of albendazole.
Topics: Adult; Albendazole; Cysticercosis; Dexamethasone; Drug Therapy, Combination; Female; Humans; Inflamm | 1990 |
Albendazole therapy for neurocysticercosis.
Topics: Albendazole; Brain Diseases; Cysticercosis; Humans; Radiography | 1990 |
Plasma and CSF levels of albendazole and praziquantel in patients with neurocysticercosis.
Topics: Adolescent; Adult; Age Factors; Aged; Albendazole; Brain Diseases; Child; Cysticercosis; Female; Hum | 1990 |
Albendazole therapy for subarachnoid and ventricular cysticercosis. Case report.
Topics: Adult; Albendazole; Brain Diseases; Cerebral Ventricles; Cerebral Ventriculography; Cysticercosis; F | 1990 |
Failure of praziquantel and albendazole in neurocysticercosis.
Topics: Adult; Albendazole; Brain Diseases; Cysticercosis; Drug Therapy, Combination; Follow-Up Studies; Hum | 1990 |
[Pharmacokinetics of albendazole and its metabolites in human body].
Topics: Adult; Albendazole; Chromatography, High Pressure Liquid; Cysticercosis; Humans; Middle Aged; Sulfon | 1990 |
Neurocysticercosis. Short course of treatment with albendazole.
Topics: Adolescent; Adult; Aged; Albendazole; Brain Diseases; Cysticercosis; Female; Humans; Male; Middle Ag | 1989 |
Praziquantel vs. albendazol for cysticercosis.
Topics: Albendazole; Anthelmintics; Benzimidazoles; Brain Diseases; Cysticercosis; Humans; Mexico; Praziquan | 1988 |
Short course of albendazole therapy for neurocysticercosis.
Topics: Adult; Albendazole; Anthelmintics; Benzimidazoles; Brain; Brain Diseases; Cysticercosis; Female; Hem | 1988 |
Albendazole vs praziquantel for therapy for neurocysticercosis. A controlled trial.
Topics: Adult; Albendazole; Benzimidazoles; Brain Diseases; Cysticercosis; Female; Humans; Male; Middle Aged | 1988 |
[Albendazole treatment in cerebral cysticercosis].
Topics: Adolescent; Adult; Aged; Albendazole; Anthelmintics; Benzimidazoles; Brain Diseases; Child; Cysticer | 1986 |
Albendazole therapy for neurocysticercosis.
Topics: Adult; Albendazole; Anthelmintics; Benzimidazoles; Brain Diseases; Cysticercosis; Female; Follow-Up | 1987 |